Background  	Background  	 NN	O
The  	The  	 DT	O
early  	early  	 JJ	O
diagnosis  	diagnosis  	 NN	O
of  	of  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
has  	has  	 VBZ	O
the  	the  	 DT	O
potential  	potential  	 JJ	O
to  	to  	 TO	O
dramatically  	dramatically  	 RB	O
reduce  	reduce  	 VB	O
the  	the  	 DT	O
mortality  	mortality  	 NN	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
this  	this  	 DT	O
disease 	disease 	 NN	O
.  	.  	 .	O
Recently 	Recently 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
surface-enhanced  	surface-enhanced  	 FW	B-NP
laser  	laser  	 FW	I-NP
desorption 	desorption 	 FW	I-NP
/ 	/ 	 FW	I-NP
ionization  	ionization  	 FW	I-NP
( 	( 	 -LRB-	O
SELDI 	SELDI 	 NNP	B-NP
)  	)  	 -RRB-	O
time-of-flight  	time-of-flight  	 JJ	B-NP
mass  	mass  	 NN	I-NP
spectrometry  	spectrometry  	 NN	I-NP
profiling  	profiling  	 NN	I-NP
of  	of  	 IN	O
patient  	patient  	 JJ	O
serum  	serum  	 JJ	B-NP
proteins 	proteins 	 NNS	I-NP
,  	,  	 ,	O
combined  	combined  	 VBN	O
with  	with  	 IN	O
advanced  	advanced  	 JJ	O
data  	data  	 NN	B-NP
mining  	mining  	 NN	I-NP
algorithms 	algorithms 	 NN	I-NP
,  	,  	 ,	O
to  	to  	 TO	O
detect  	detect  	 VB	O
protein  	protein  	 NN	B-NP
patterns  	patterns  	 NNS	I-NP
associated  	associated  	 VBN	O
with  	with  	 IN	O
malignancy 	malignancy 	 NN	B-NP
,  	,  	 ,	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
reported  	reported  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
promising  	promising  	 JJ	O
field  	field  	 NN	O
of  	of  	 IN	O
research  	research  	 NN	O
to  	to  	 TO	O
achieve  	achieve  	 VB	O
the  	the  	 DT	O
goal  	goal  	 NN	O
of  	of  	 IN	O
early  	early  	 JJ	O
cancer  	cancer  	 NN	B-NP
detection  	detection  	 NNS	I-NP
[  	[  	 -LRB-	O
1  	1  	 CD	O
2  	2  	 CD	O
3  	3  	 CD	O
4  	4  	 CD	O
5  	5  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Several  	Several  	 JJ	O
reports  	reports  	 NNS	O
have  	have  	 VBP	O
detailed  	detailed  	 VBN	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
proteomic  	proteomic  	 JJ	B-NP
method  	method  	 NN	I-NP
to  	to  	 TO	O
diagnose  	diagnose  	 VB	O
the  	the  	 DT	O
difference  	difference  	 NN	O
between  	between  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
[  	[  	 -LRB-	O
6  	6  	 CD	O
7  	7  	 CD	O
8  	8  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
prostate  	prostate  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
[  	[  	 -LRB-	O
9  	9  	 CD	O
10  	10  	 CD	O
11  	11  	 CD	O
12  	12  	 CD	O
13  	13  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
bladder  	bladder  	 JJ	O
cancer  	cancer  	 NN	O
[  	[  	 -LRB-	O
13  	13  	 CD	O
14  	14  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Much  	Much  	 RB	O
of  	of  	 IN	O
the  	the  	 DT	O
effort  	effort  	 NN	O
in  	in  	 IN	O
these  	these  	 DT	O
analyses  	analyses  	 NN	O
has  	has  	 VBZ	O
focused  	focused  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
variety  	variety  	 NN	O
of  	of  	 IN	O
data  	data  	 NN	O
mining  	mining  	 NN	O
tools  	tools  	 NNS	O
such  	such  	 JJ	O
as  	as  	 IN	O
the  	the  	 DT	O
evaluation  	evaluation  	 NN	O
of  	of  	 IN	O
prostate  	prostate  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
using  	using  	 VBG	O
peaks  	peaks  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
mass  	mass  	 NN	O
to  	to  	 TO	O
charge  	charge  	 VB	O
( 	( 	 -LRB-	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z 	Z 	 NNP	I-NP
)  	)  	 -RRB-	O
region  	region  	 NN	O
between  	between  	 IN	O
2  	2  	 CD	O
K  	K  	 NNP	O
and  	and  	 CC	O
40  	40  	 CD	O
K  	K  	 NN	O
combined  	combined  	 VBN	O
with  	with  	 IN	O
boosted  	boosted  	 JJ	O
decision  	decision  	 NN	B-NP
tree  	tree  	 NN	I-NP
analysis  	analysis  	 NN	I-NP
[  	[  	 -LRB-	O
10  	10  	 CD	O
]  	]  	 -RRB-	O
to  	to  	 TO	O
try  	try  	 VB	O
to  	to  	 TO	O
detect  	detect  	 VB	O
patterns  	patterns  	 NNS	O
that  	that  	 WDT	O
allow  	allow  	 VBP	O
the  	the  	 DT	O
diagnosis  	diagnosis  	 NN	O
of  	of  	 IN	O
cancer  	cancer  	 NN	O
versus  	versus  	 IN	O
non-cancer 	non-cancer 	 JJ	B-NP
.  	.  	 .	O
The  	The  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
similar  	similar  	 JJ	O
technology  	technology  	 NN	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
bladder  	bladder  	 JJ	O
cancer  	cancer  	 NN	O
has  	has  	 VBZ	O
also  	also  	 RB	O
been  	been  	 VBN	O
reported  	reported  	 VBN	O
[  	[  	 -LRB-	O
13  	13  	 CD	O
14  	14  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
this  	this  	 DT	O
field  	field  	 NN	O
represents  	represents  	 VBZ	O
an  	an  	 DT	O
active  	active  	 JJ	O
area  	area  	 NN	O
of  	of  	 IN	O
current  	current  	 JJ	O
research 	research 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
recent  	recent  	 JJ	O
report  	report  	 NN	O
by  	by  	 IN	O
the  	the  	 DT	O
Clinical  	Clinical  	 NNP	B-NP
Proteomics  	Proteomics  	 NNP	I-NP
Program  	Program  	 NNP	I-NP
Databank  	Databank  	 NNP	I-NP
has  	has  	 VBZ	O
demonstrated  	demonstrated  	 VBN	O
that  	that  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
genetic  	genetic  	 JJ	B-NP
algorithms  	algorithms  	 NNS	I-NP
coupled  	coupled  	 VBN	O
with  	with  	 IN	O
clustering  	clustering  	 JJ	O
analysis  	analysis  	 NN	O
has  	has  	 VBZ	O
resulted  	resulted  	 VBN	O
in  	in  	 IN	O
rule  	rule  	 NN	B-NP
sets  	sets  	 NNS	I-NP
that  	that  	 WDT	O
can  	can  	 MD	O
predict  	predict  	 VB	O
ovarian  	ovarian  	 JJ	B-NP
cancers  	cancers  	 NNS	I-NP
( 	( 	 -LRB-	O
including  	including  	 VBG	B-NP
samples  	samples  	 NNS	I-NP
from  	from  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
stage  	stage  	 NN	O
1  	1  	 CD	O
disease 	disease 	 NN	O
)  	)  	 -RRB-	O
with  	with  	 IN	O
100 	100 	 CD	O
%  	%  	 NN	O
sensitivity  	sensitivity  	 NN	O
and  	and  	 CC	O
96 	96 	 CD	O
%  	%  	 NN	O
specificity  	specificity  	 NNS	O
[  	[  	 -LRB-	O
6  	6  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
have  	have  	 VBP	O
been  	been  	 VBN	O
extended  	extended  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
group  	group  	 NN	O
to  	to  	 TO	O
include  	include  	 VB	O
a  	a  	 DT	O
larger  	larger  	 JJR	O
series  	series  	 NN	O
of  	of  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
patients  	patients  	 NNS	I-NP
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
prostate  	prostate  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
patients  	patients  	 NNS	I-NP
[  	[  	 -LRB-	O
7  	7  	 CD	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
Clinical  	Clinical  	 NNP	B-NP
Proteomics  	Proteomics  	 NNP	I-NP
Program  	Program  	 NNP	I-NP
Databank  	Databank  	 NNP	I-NP
has  	has  	 VBZ	O
provided  	provided  	 VBN	O
three  	three  	 CD	O
sets  	sets  	 NNS	O
of  	of  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
data  	data  	 NNS	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
scientific  	scientific  	 JJ	B-NP
community  	community  	 NN	I-NP
without  	without  	 IN	O
restriction 	restriction 	 NN	O
.  	.  	 .	O
These  	These  	 DT	O
data  	data  	 NN	O
sets  	sets  	 NNS	O
include  	include  	 VBP	O
Lancet  	Lancet  	 NNP	B-NP
Ovarian  	Ovarian  	 NNP	I-NP
Data  	Data  	 NNP	I-NP
2-16-02  	2-16-02  	 NNP	O
used  	used  	 VBD	O
in  	in  	 IN	O
the  	the  	 DT	O
study  	study  	 NN	O
noted  	noted  	 VBD	O
above  	above  	 IN	O
[  	[  	 -LRB-	O
6  	6  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
study  	study  	 NN	O
consisted  	consisted  	 VBD	O
of  	of  	 IN	O
a  	a  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
100  	100  	 CD	O
control 	control 	 NN	O
,  	,  	 ,	O
100  	100  	 CD	O
cancer 	cancer 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
16  	16  	 CD	O
benign  	benign  	 JJ	B-NP
disease  	disease  	 NN	I-NP
samples  	samples  	 NNS	I-NP
run  	run  	 VBN	O
on  	on  	 IN	O
a  	a  	 DT	O
Ciphergen  	Ciphergen  	 NNP	B-NP
H4  	H4  	 NNP	I-NP
ProteinChip  	ProteinChip  	 JJ	I-NP
array  	array  	 NN	I-NP
( 	( 	 -LRB-	O
since  	since  	 IN	O
discontinued 	discontinued 	 JJ	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
samples  	samples  	 NNS	O
were  	were  	 VBD	O
manually  	manually  	 RB	O
processed 	processed 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
data  	data  	 NNS	O
was  	was  	 VBD	O
posted  	posted  	 VBN	O
after  	after  	 IN	O
baseline  	baseline  	 JJ	B-NP
subtraction 	subtraction 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
second  	second  	 JJ	O
data  	data  	 NNS	O
set 	set 	 VBN	O
,  	,  	 ,	O
Ovarian  	Ovarian  	 NNP	B-NP
Dataset  	Dataset  	 NNP	I-NP
4-3-02  	4-3-02  	 NNP	O
consist  	consist  	 VBP	O
of  	of  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
samples  	samples  	 NNS	O
as  	as  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
but  	but  	 CC	O
the  	the  	 DT	O
samples  	samples  	 NNS	O
were  	were  	 VBD	O
run  	run  	 VBN	O
on  	on  	 IN	O
a  	a  	 DT	O
Ciphergen  	Ciphergen  	 NNP	B-NP
WCX2  	WCX2  	 NNP	I-NP
ProteinChip  	ProteinChip  	 JJ	I-NP
array 	array 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
samples  	samples  	 NNS	O
were  	were  	 VBD	O
manually  	manually  	 RB	O
prepared  	prepared  	 VBN	O
and  	and  	 CC	O
the  	the  	 DT	O
data  	data  	 NNS	O
was  	was  	 VBD	O
posted  	posted  	 VBN	O
with  	with  	 IN	O
baseline  	baseline  	 JJ	B-NP
subtraction 	subtraction 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
model  	model  	 NN	O
diagnostic  	diagnostic  	 JJ	B-NP
rule  	rule  	 NN	I-NP
based  	based  	 VBN	O
on  	on  	 IN	O
this  	this  	 DT	O
dataset  	dataset  	 NN	B-NP
is  	is  	 VBZ	O
published  	published  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
website 	website 	 NN	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
no  	no  	 DT	O
data  	data  	 NN	O
is  	is  	 VBZ	O
given  	given  	 VBN	O
regarding  	regarding  	 VBG	O
the  	the  	 DT	O
rules  	rules  	 NNS	O
sensitivity  	sensitivity  	 NN	O
or  	or  	 CC	O
specificity 	specificity 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
report 	report 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
analyze  	analyze  	 VBP	O
the  	the  	 DT	O
third  	third  	 JJ	O
Ovarian  	Ovarian  	 NNP	B-NP
Dataset  	Dataset  	 NNP	I-NP
8-7-02  	8-7-02  	 NNP	O
and  	and  	 CC	O
corresponding  	corresponding  	 JJ	O
sample  	sample  	 NN	O
information  	information  	 NN	O
downloaded  	downloaded  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
Clinical  	Clinical  	 NNP	B-NP
Proteomics  	Proteomics  	 NNP	I-NP
Program  	Program  	 NNP	I-NP
Databank  	Databank  	 NNP	I-NP
website  	website  	 NNS	I-NP
[  	[  	 -LRB-	O
7  	7  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
set  	set  	 NN	O
of  	of  	 IN	O
data  	data  	 NN	O
consists  	consists  	 VBZ	O
of  	of  	 IN	O
serum  	serum  	 JJ	B-NP
profiles  	profiles  	 NNS	I-NP
of  	of  	 IN	O
162  	162  	 CD	O
subjects  	subjects  	 NNS	B-NP
with  	with  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
and  	and  	 CC	O
91  	91  	 CD	O
non-cancer  	non-cancer  	 JJ	B-NP
control  	control  	 NN	I-NP
subjects 	subjects 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
cancer  	cancer  	 NN	B-NP
group  	group  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
further  	further  	 RB	O
divided  	divided  	 VBN	O
into  	into  	 IN	O
28  	28  	 CD	O
stage  	stage  	 NN	O
1  	1  	 CD	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
20  	20  	 CD	O
stage  	stage  	 NN	O
2  	2  	 CD	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
99  	99  	 CD	O
stage  	stage  	 NN	O
3  	3  	 CD	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
12  	12  	 CD	O
stage  	stage  	 NN	O
4  	4  	 CD	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
3  	3  	 CD	O
no  	no  	 DT	O
stage  	stage  	 NN	O
specified  	specified  	 VBN	O
patients 	patients 	 NNS	O
.  	.  	 .	O
For  	For  	 IN	O
each  	each  	 DT	O
subject  	subject  	 NN	B-NP
a  	a  	 DT	O
set  	set  	 NN	O
of  	of  	 IN	O
data  	data  	 NNS	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
intensities  	intensities  	 NN	O
at  	at  	 IN	O
15,154  	15,154  	 CD	O
distinct  	distinct  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
ranging  	ranging  	 VBG	O
from  	from  	 IN	O
0.0000786  	0.0000786  	 CD	O
to  	to  	 TO	O
19995.513  	19995.513  	 NNP	O
was  	was  	 VBD	O
available  	available  	 JJ	O
for  	for  	 IN	O
analysis 	analysis 	 NN	O
.  	.  	 .	O
This  	This  	 DT	O
dataset  	dataset  	 NN	B-NP
was  	was  	 VBD	O
constructed  	constructed  	 VBN	O
using  	using  	 VBG	O
the  	the  	 DT	O
Ciphergen  	Ciphergen  	 NNP	B-NP
WCX2  	WCX2  	 NNP	I-NP
ProteinChip  	ProteinChip  	 JJ	I-NP
array 	array 	 NN	I-NP
.  	.  	 .	O
All  	All  	 PDT	O
the  	the  	 DT	O
steps  	steps  	 NNS	O
of  	of  	 IN	O
preparing  	preparing  	 VBG	O
the  	the  	 DT	O
chips  	chips  	 NNS	O
for  	for  	 IN	O
sample  	sample  	 NN	O
analysis  	analysis  	 NN	O
were  	were  	 VBD	O
preformed  	preformed  	 JJ	O
robotically 	robotically 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
raw  	raw  	 JJ	O
data  	data  	 NNS	O
without  	without  	 IN	O
baseline  	baseline  	 JJ	B-NP
subtraction  	subtraction  	 NN	I-NP
was  	was  	 VBD	O
posted  	posted  	 VBN	O
for  	for  	 IN	O
download 	download 	 NN	B-NP
.  	.  	 .	O
A  	A  	 DT	O
model  	model  	 NN	B-NP
rule  	rule  	 NN	I-NP
claiming  	claiming  	 VBG	O
100 	100 	 CD	O
%  	%  	 NN	O
sensitivity  	sensitivity  	 NN	O
and  	and  	 CC	O
specificity  	specificity  	 NN	O
is  	is  	 VBZ	O
also  	also  	 RB	O
given 	given 	 VBN	O
.  	.  	 .	O
Additional  	Additional  	 JJ	B-NP
details  	details  	 NNS	I-NP
of  	of  	 IN	I-NP
experimental  	experimental  	 JJ	I-NP
data  	data  	 NN	I-NP
collection  	collection  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
found  	found  	 VBN	O
at  	at  	 IN	O
the  	the  	 DT	O
Clinical  	Clinical  	 NNP	B-NP
Proteomics  	Proteomics  	 NNP	I-NP
Data  	Data  	 NNP	I-NP
Bank  	Bank  	 NNP	I-NP
[  	[  	 -LRB-	O
5  	5  	 LS	O
]  	]  	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
addition  	addition  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
various  	various  	 JJ	O
methods  	methods  	 NNS	O
of  	of  	 IN	O
preparing  	preparing  	 VBG	O
and  	and  	 CC	O
running  	running  	 VBG	O
the  	the  	 DT	O
samples  	samples  	 NNS	O
on  	on  	 IN	O
the  	the  	 DT	O
mass  	mass  	 JJ	B-NP
spectrometer 	spectrometer 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
optimal  	optimal  	 JJ	B-NP
steps  	steps  	 NNS	I-NP
in  	in  	 IN	O
processing  	processing  	 VBG	O
the  	the  	 DT	O
raw  	raw  	 JJ	O
data  	data  	 NNS	O
from  	from  	 IN	O
the  	the  	 DT	O
mass  	mass  	 JJ	B-NP
spectrometer  	spectrometer  	 NN	I-NP
for  	for  	 IN	O
further  	further  	 JJ	O
analysis  	analysis  	 NN	O
have  	have  	 VBP	O
not  	not  	 RB	O
been  	been  	 VBN	O
standardized  	standardized  	 JJ	O
and  	and  	 CC	O
remain  	remain  	 VB	O
a  	a  	 DT	O
fertile  	fertile  	 JJ	O
area  	area  	 NN	O
for  	for  	 IN	O
investigation  	investigation  	 NN	B-NP
[  	[  	 -LRB-	O
15  	15  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
We  	We  	 PRP	O
choose  	choose  	 VBP	O
the  	the  	 DT	O
deliberately  	deliberately  	 RB	O
simple  	simple  	 JJ	O
strategy  	strategy  	 NN	O
of  	of  	 IN	O
using  	using  	 VBG	O
Wilcoxon  	Wilcoxon  	 JJ	B-NP
test  	test  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
raw  	raw  	 JJ	O
data  	data  	 NNS	O
to  	to  	 TO	O
better  	better  	 RB	O
understand  	understand  	 VB	O
the  	the  	 DT	O
underlying  	underlying  	 JJ	O
properties  	properties  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
data  	data  	 NNS	O
set 	set 	 VBN	O
.  	.  	 .	O
We  	We  	 PRP	O
consider  	consider  	 VBP	O
this  	this  	 DT	O
simple  	simple  	 JJ	O
approach  	approach  	 NN	O
a  	a  	 DT	O
"benchmark  	"benchmark  	 JJ	O
method 	method 	 NN	O
"  	"  	 ''	O
to  	to  	 TO	O
which  	which  	 WDT	O
other  	other  	 JJ	O
methods  	methods  	 NNS	O
can  	can  	 MD	O
be  	be  	 VB	O
compared 	compared 	 VBN	O
.  	.  	 .	O
Further 	Further 	 RB	O
,  	,  	 ,	O
we  	we  	 PRP	O
use  	use  	 VBP	O
Wilcoxon  	Wilcoxon  	 JJ	B-NP
test  	test  	 NN	I-NP
and  	and  	 CC	O
stepwise  	stepwise  	 JJ	B-NP
discriminant  	discriminant  	 JJ	I-NP
analysis  	analysis  	 NN	I-NP
on  	on  	 IN	O
a  	a  	 DT	O
training  	training  	 NN	O
subset  	subset  	 VBZ	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
80  	80  	 CD	O
cancer  	cancer  	 NN	B-NP
patients  	patients  	 NNS	I-NP
and  	and  	 CC	O
45  	45  	 CD	O
controls 	controls 	 NNS	O
,  	,  	 ,	O
randomly  	randomly  	 RB	O
chosen  	chosen  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
original  	original  	 JJ	B-NP
data  	data  	 NNS	I-NP
set 	set 	 VBN	O
,  	,  	 ,	O
to  	to  	 TO	O
develop  	develop  	 VB	O
rules  	rules  	 NNS	O
to  	to  	 TO	O
classify  	classify  	 VB	O
a  	a  	 DT	O
test  	test  	 NN	O
set  	set  	 VBD	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
the  	the  	 DT	O
remaining  	remaining  	 JJ	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
control  	control  	 NN	B-NP
subjects 	subjects 	 NNS	I-NP
.  	.  	 .	O
Disease  	Disease  	 NN	B-NP
classifiers  	classifiers  	 NN	I-NP
of  	of  	 IN	O
great  	great  	 JJ	O
sensitivity  	sensitivity  	 NN	O
and  	and  	 CC	O
specificity  	specificity  	 NN	O
could  	could  	 MD	O
be  	be  	 VB	O
readily  	readily  	 RB	O
constructed  	constructed  	 VBN	O
by  	by  	 IN	O
visual  	visual  	 JJ	O
inspection  	inspection  	 NN	O
and  	and  	 CC	O
manual  	manual  	 JJ	B-NP
binning  	binning  	 NN	I-NP
of  	of  	 IN	I-NP
M 	M 	 NNP	I-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
p-values  	p-values  	 JJ	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
Wilcoxon  	Wilcoxon  	 JJ	I-NP
test  	test  	 NN	I-NP
combined  	combined  	 VBN	O
with  	with  	 IN	O
classical  	classical  	 JJ	B-NP
stepwise  	stepwise  	 JJ	I-NP
discriminant  	discriminant  	 JJ	I-NP
analysis 	analysis 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
ability  	ability  	 NN	B-NP
of  	of  	 IN	O
these  	these  	 DT	O
rules  	rules  	 NNS	O
to  	to  	 TO	O
classify  	classify  	 VB	O
disease  	disease  	 NN	O
and  	and  	 CC	O
normal  	normal  	 JJ	B-NP
samples  	samples  	 NNS	I-NP
were  	were  	 VBD	O
comparable  	comparable  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
model  	model  	 NN	B-NP
rule  	rule  	 NN	I-NP
published  	published  	 VBN	O
on  	on  	 IN	O
this  	this  	 DT	O
dataset  	dataset  	 NN	B-NP
at  	at  	 IN	O
the  	the  	 DT	O
Clinical  	Clinical  	 NNP	B-NP
Proteomics  	Proteomics  	 NNP	I-NP
Program  	Program  	 NNP	I-NP
Databank  	Databank  	 NNP	I-NP
website  	website  	 NN	I-NP
which  	which  	 WDT	O
was  	was  	 VBD	O
developed  	developed  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
proprietary  	proprietary  	 JJ	B-NP
genetic  	genetic  	 JJ	I-NP
algorithm 	algorithm 	 NN	I-NP
.  	.  	 .	O
Further 	Further 	 RB	O
,  	,  	 ,	O
in  	in  	 IN	O
examining  	examining  	 VBG	O
all  	all  	 DT	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values 	values 	 NNS	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
that  	that  	 WDT	O
discriminated  	discriminated  	 VBP	O
best  	best  	 RB	O
between  	between  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
and  	and  	 CC	O
control  	control  	 NN	O
were  	were  	 VBD	O
all  	all  	 DT	O
found  	found  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
less  	less  	 JJR	O
than  	than  	 IN	O
500 	500 	 CD	O
,  	,  	 ,	O
an  	an  	 DT	O
area  	area  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
spectrum  	spectrum  	 NN	B-NP
often  	often  	 RB	O
discarded  	discarded  	 VBN	O
as  	as  	 IN	O
noise  	noise  	 NN	O
[  	[  	 -LRB-	O
10  	10  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
findings  	findings  	 NNS	O
are  	are  	 VBP	O
useful  	useful  	 JJ	O
for  	for  	 IN	O
several  	several  	 JJ	O
reasons 	reasons 	 NNS	O
.  	.  	 .	O
First 	First 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
statistical  	statistical  	 JJ	B-NP
methods  	methods  	 NNS	I-NP
used  	used  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
are  	are  	 VBP	O
readily  	readily  	 RB	O
available 	available 	 JJ	O
,  	,  	 ,	O
widely  	widely  	 RB	O
understood 	understood 	 VBN	O
,  	,  	 ,	O
and  	and  	 CC	O
can  	can  	 MD	O
be  	be  	 VB	O
cheaply  	cheaply  	 RB	O
implemented 	implemented 	 VBN	O
.  	.  	 .	O
Secondly 	Secondly 	 RB	O
,  	,  	 ,	O
a  	a  	 DT	O
vast  	vast  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
mathematical  	mathematical  	 JJ	B-NP
research  	research  	 NN	I-NP
and  	and  	 CC	O
practical  	practical  	 JJ	B-NP
experience  	experience  	 NN	I-NP
underlies  	underlies  	 VBD	O
their  	their  	 PRP$	O
interpretation 	interpretation 	 NN	B-NP
.  	.  	 .	O
Finally 	Finally 	 RB	O
,  	,  	 ,	O
they  	they  	 PRP	O
can  	can  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
discover  	discover  	 VB	O
unexpected  	unexpected  	 JJ	O
patterns  	patterns  	 NNS	O
present  	present  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
data  	data  	 NNS	O
set 	set 	 VBN	O
.  	.  	 .	O
These  	These  	 DT	O
patterns  	patterns  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
missed  	missed  	 VBN	O
by  	by  	 IN	O
machine  	machine  	 NN	O
learning  	learning  	 VBG	B-NP
methods  	methods  	 NNS	I-NP
that  	that  	 WDT	O
are  	are  	 VBP	O
narrowly  	narrowly  	 RB	O
focused  	focused  	 VBN	O
on  	on  	 IN	O
diagnostic  	diagnostic  	 JJ	B-NP
classification 	classification 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
do  	do  	 VBP	O
not  	not  	 RB	O
present  	present  	 VB	O
the  	the  	 DT	O
researcher  	researcher  	 NN	O
with  	with  	 IN	O
a  	a  	 DT	O
broad  	broad  	 JJ	O
overview  	overview  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
data 	data 	 NNS	O
.  	.  	 .	O
As  	As  	 IN	O
a  	a  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
these  	these  	 DT	O
traditional  	traditional  	 JJ	O
studies 	studies 	 NNS	O
,  	,  	 ,	O
a  	a  	 DT	O
better  	better  	 JJR	O
understanding  	understanding  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
weaknesses  	weaknesses  	 NNS	O
and  	and  	 CC	O
possible  	possible  	 JJ	O
strengths  	strengths  	 NNS	O
of  	of  	 IN	O
serum  	serum  	 JJ	B-NP
proteomic  	proteomic  	 JJ	I-NP
profiling  	profiling  	 NN	I-NP
becomes  	becomes  	 VBZ	O
apparent 	apparent 	 JJ	O
.  	.  	 .	O
Results  	Results  	 NNS	O
and  	and  	 CC	O
Discussion  	Discussion  	 NNP	O
Based  	Based  	 NNP	O
on  	on  	 IN	O
the  	the  	 DT	O
initial  	initial  	 JJ	O
training  	training  	 NN	B-NP
set 	set 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
intensity  	intensity  	 NN	O
at  	at  	 IN	O
each  	each  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
consecutive  	consecutive  	 JJ	O
15,154  	15,154  	 NNP	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
was  	was  	 VBD	O
first  	first  	 RB	O
compared  	compared  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
two-sided  	two-sided  	 JJ	O
Wilcoxon  	Wilcoxon  	 JJ	B-NP
test  	test  	 NN	I-NP
( 	( 	 -LRB-	O
see  	see  	 VB	O
methods 	methods 	 NNS	O
)  	)  	 -RRB-	O
Figure  	Figure  	 NN	O
1shows  	1shows  	 VBZ	O
the  	the  	 DT	O
pattern  	pattern  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
resulting  	resulting  	 VBG	O
two-sided  	two-sided  	 JJ	O
Wilcoxon  	Wilcoxon  	 JJ	B-NP
test  	test  	 NN	I-NP
p-values  	p-values  	 NN	I-NP
generated  	generated  	 VBD	O
on  	on  	 IN	O
a  	a  	 DT	O
training  	training  	 NN	O
set  	set  	 VBD	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
80  	80  	 CD	O
cancer  	cancer  	 NN	B-NP
patients  	patients  	 NNS	I-NP
and  	and  	 CC	O
45  	45  	 CD	O
controls  	controls  	 NNS	O
randomly  	randomly  	 RB	O
chosen  	chosen  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
larger  	larger  	 JJR	O
data  	data  	 NNS	O
set 	set 	 VBN	O
,  	,  	 ,	O
with  	with  	 IN	O
the  	the  	 DT	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
x-axis  	x-axis  	 JJ	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
negative  	negative  	 JJ	B-NP
logarithm  	logarithm  	 NNS	I-NP
( 	( 	 -LRB-	O
base  	base  	 NN	O
10 	10 	 CD	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
the  	the  	 DT	O
Wilcoxon  	Wilcoxon  	 JJ	B-NP
test  	test  	 NN	I-NP
p-values  	p-values  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
y-axis 	y-axis 	 JJ	B-NP
.  	.  	 .	O
There  	There  	 EX	O
are  	are  	 VBP	O
a  	a  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
685  	685  	 CD	O
distinct  	distinct  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
differing  	differing  	 VBG	O
between  	between  	 IN	O
the  	the  	 DT	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
control  	control  	 NN	B-NP
populations  	populations  	 NNS	I-NP
with  	with  	 IN	O
a  	a  	 DT	O
p-value  	p-value  	 JJ	B-NP
of  	of  	 IN	O
less  	less  	 JJR	O
than  	than  	 IN	O
10  	10  	 CD	O
-6 	-6 	 CD	O
.  	.  	 .	O
Also  	Also  	 RB	O
of  	of  	 IN	O
note  	note  	 NN	O
in  	in  	 IN	O
this  	this  	 DT	O
distribution  	distribution  	 NN	B-NP
is  	is  	 VBZ	O
that  	that  	 IN	O
all  	all  	 DT	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
with  	with  	 IN	O
a  	a  	 DT	O
Wilcoxon  	Wilcoxon  	 NNP	B-NP
p-value  	p-value  	 NNP	I-NP
less  	less  	 RBR	O
than  	than  	 IN	O
10  	10  	 CD	O
-12are  	-12are  	 CD	O
found  	found  	 VBN	O
at  	at  	 IN	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	O
less  	less  	 JJR	O
than  	than  	 IN	O
500 	500 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
significance  	significance  	 NN	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
finding  	finding  	 NN	O
will  	will  	 MD	O
be  	be  	 VB	O
discussed  	discussed  	 VBN	O
further  	further  	 RBR	O
below 	below 	 RB	O
.  	.  	 .	O
In  	In  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
determine  	determine  	 VB	O
if  	if  	 IN	O
these  	these  	 DT	O
data  	data  	 NNS	O
could  	could  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
separate  	separate  	 VB	O
normal  	normal  	 JJ	O
from  	from  	 IN	O
cancer 	cancer 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
used  	used  	 VBD	O
three  	three  	 CD	O
strategies  	strategies  	 NNS	O
to  	to  	 TO	O
develop  	develop  	 VB	O
rules  	rules  	 NNS	O
for  	for  	 IN	O
diagnostic  	diagnostic  	 JJ	B-NP
classification 	classification 	 NN	I-NP
.  	.  	 .	O
First 	First 	 NNP	O
,  	,  	 ,	O
all  	all  	 DT	O
data  	data  	 NN	O
points  	points  	 NNS	O
regardless  	regardless  	 RB	O
of  	of  	 IN	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
value  	value  	 NN	I-NP
were  	were  	 VBD	O
sorted  	sorted  	 VBN	O
from  	from  	 IN	O
most  	most  	 JJS	O
to  	to  	 TO	O
least  	least  	 JJS	O
significant  	significant  	 JJ	O
( 	( 	 -LRB-	O
according  	according  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
two-sided  	two-sided  	 JJ	O
Wilcoxon  	Wilcoxon  	 JJ	B-NP
test  	test  	 NN	I-NP
p-values 	p-values 	 NN	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
the  	the  	 DT	O
100  	100  	 CD	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
lowest  	lowest  	 JJS	O
p-values  	p-values  	 NN	B-NP
were  	were  	 VBD	O
chosen 	chosen 	 VBN	O
.  	.  	 .	O
These  	These  	 DT	O
100  	100  	 CD	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
were  	were  	 VBD	O
then  	then  	 RB	O
separated  	separated  	 VBN	O
into  	into  	 IN	O
distinct  	distinct  	 JJ	O
bins  	bins  	 NN	O
by  	by  	 IN	O
sorting  	sorting  	 VBG	O
on  	on  	 IN	O
consecutive  	consecutive  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
and  	and  	 CC	O
requiring  	requiring  	 VBG	O
a  	a  	 DT	O
separation  	separation  	 NN	O
of  	of  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
1  	1  	 CD	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
value  	value  	 NN	I-NP
to  	to  	 TO	O
start  	start  	 VB	O
the  	the  	 DT	O
next  	next  	 JJ	O
bin  	bin  	 NNS	O
( 	( 	 -LRB-	O
12  	12  	 CD	O
bins  	bins  	 NNS	O
were  	were  	 VBD	O
detected  	detected  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
process 	process 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
value  	value  	 NN	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
smallest  	smallest  	 JJS	O
p-value  	p-value  	 JJ	B-NP
in  	in  	 IN	O
each  	each  	 DT	O
bin  	bin  	 NN	O
was  	was  	 VBD	O
selected 	selected 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
results  	results  	 NNS	O
are  	are  	 VBP	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Table  	Table  	 NNP	O
1 	1 	 CD	O
.  	.  	 .	O
Next 	Next 	 JJ	O
,  	,  	 ,	O
stepwise  	stepwise  	 JJ	O
discriminate  	discriminate  	 JJ	O
analysis  	analysis  	 NN	O
was  	was  	 VBD	O
performed 	performed 	 VBN	O
,  	,  	 ,	O
and  	and  	 CC	O
7  	7  	 CD	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
were  	were  	 VBD	O
selected  	selected  	 VBN	O
for  	for  	 IN	O
Rule  	Rule  	 NNP	O
1  	1  	 CD	O
( 	( 	 -LRB-	O
of  	of  	 IN	O
note 	note 	 NN	O
,  	,  	 ,	O
all  	all  	 DT	O
but  	but  	 CC	O
one  	one  	 CD	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
value  	value  	 NN	I-NP
was  	was  	 VBD	O
below  	below  	 IN	O
500 	500 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
When  	When  	 WRB	O
this  	this  	 DT	O
rule  	rule  	 NN	O
was  	was  	 VBD	O
applied  	applied  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
entire  	entire  	 JJ	O
data  	data  	 NNS	O
set 	set 	 VBN	O
,  	,  	 ,	O
test  	test  	 NN	O
and  	and  	 CC	O
training  	training  	 NN	O
inclusive 	inclusive 	 NN	O
,  	,  	 ,	O
all  	all  	 DT	O
162  	162  	 CD	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
91  	91  	 CD	O
controls  	controls  	 NNS	O
were  	were  	 VBD	O
appropriately  	appropriately  	 RB	O
classified  	classified  	 VBN	O
without  	without  	 IN	O
error  	error  	 NN	O
for  	for  	 IN	O
100 	100 	 CD	O
%  	%  	 NN	O
sensitivity  	sensitivity  	 NN	O
and  	and  	 CC	O
specificity 	specificity 	 NN	O
.  	.  	 .	O
Given  	Given  	 VBN	O
that  	that  	 IN	O
the  	the  	 DT	O
interpretation  	interpretation  	 NN	B-NP
of  	of  	 IN	O
low  	low  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
maybe  	maybe  	 RB	O
problematic 	problematic 	 JJ	O
,  	,  	 ,	O
we  	we  	 PRP	O
next  	next  	 RB	O
focused  	focused  	 VBN	B-NP
attention  	attention  	 NN	I-NP
on  	on  	 IN	O
a  	a  	 DT	O
set  	set  	 NN	O
of  	of  	 IN	O
rules  	rules  	 NNS	O
which  	which  	 WDT	O
met  	met  	 VBD	O
the  	the  	 DT	O
following  	following  	 JJ	O
requirements 	requirements 	 NNS	B-NP
.  	.  	 .	O
First 	First 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
value  	value  	 NN	I-NP
had  	had  	 VBD	O
to  	to  	 TO	O
exceed  	exceed  	 VB	O
2000 	2000 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
Wilcoxon  	Wilcoxon  	 JJ	B-NP
test  	test  	 NN	I-NP
P-value  	P-value  	 NN	I-NP
had  	had  	 VBD	O
to  	to  	 TO	O
be  	be  	 VB	O
less  	less  	 JJR	O
than  	than  	 IN	O
10  	10  	 CD	O
-6 	-6 	 CD	O
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
462  	462  	 CD	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
training  	training  	 NN	O
set  	set  	 VBD	O
met  	met  	 VBN	O
these  	these  	 DT	O
criteria 	criteria 	 NNS	O
.  	.  	 .	O
As  	As  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Table  	Table  	 NNP	O
2 	2 	 CD	O
,  	,  	 ,	O
a  	a  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
30  	30  	 CD	O
bins  	bins  	 NNS	O
were  	were  	 VBD	O
detected  	detected  	 VBN	O
by  	by  	 IN	O
sorting  	sorting  	 VBG	O
on  	on  	 IN	O
consecutive  	consecutive  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
as  	as  	 RB	O
above 	above 	 RB	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
most  	most  	 RBS	O
significant  	significant  	 JJ	O
p-value  	p-value  	 NN	B-NP
from  	from  	 IN	O
each  	each  	 DT	O
bin  	bin  	 NN	O
was  	was  	 VBD	O
selected  	selected  	 VBN	O
for  	for  	 IN	O
stepwise  	stepwise  	 JJ	B-NP
discriminant  	discriminant  	 JJ	I-NP
analysis 	analysis 	 NN	I-NP
.  	.  	 .	O
Thirteen  	Thirteen  	 NNP	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
were  	were  	 VBD	O
retained  	retained  	 VBN	O
in  	in  	 IN	O
Rule  	Rule  	 NNP	O
2 	2 	 CD	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
training  	training  	 NN	B-NP
set 	set 	 NN	I-NP
,  	,  	 ,	O
one  	one  	 CD	O
subject  	subject  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
cancer  	cancer  	 NN	B-NP
group  	group  	 NN	I-NP
was  	was  	 VBD	O
misclassified  	misclassified  	 VBN	O
as  	as  	 IN	O
normal  	normal  	 JJ	O
and  	and  	 CC	O
one  	one  	 CD	O
in  	in  	 IN	O
the  	the  	 DT	O
control  	control  	 NN	B-NP
group  	group  	 NN	I-NP
was  	was  	 VBD	O
misclassified  	misclassified  	 VBN	O
as  	as  	 IN	O
cancer 	cancer 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
test  	test  	 NN	B-NP
set 	set 	 NN	I-NP
,  	,  	 ,	O
two  	two  	 CD	O
subjects  	subjects  	 NNS	B-NP
from  	from  	 IN	O
the  	the  	 DT	O
control  	control  	 NN	B-NP
group  	group  	 NN	I-NP
were  	were  	 VBD	O
misclassified  	misclassified  	 VBN	O
as  	as  	 IN	O
cancer 	cancer 	 NN	O
.  	.  	 .	O
Therefore  	Therefore  	 RB	O
for  	for  	 IN	O
the  	the  	 DT	O
test  	test  	 NN	B-NP
set 	set 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
sensitivity  	sensitivity  	 NN	O
was  	was  	 VBD	O
82 	82 	 CD	O
/ 	/ 	 CD	O
82  	82  	 CD	O
or  	or  	 CC	O
100 	100 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
the  	the  	 DT	O
specificity  	specificity  	 NN	O
was  	was  	 VBD	O
43 	43 	 CD	O
/ 	/ 	 CD	O
45  	45  	 CD	O
or  	or  	 CC	O
95.7 	95.7 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
the  	the  	 DT	O
test  	test  	 NN	O
and  	and  	 CC	O
training  	training  	 NN	O
set  	set  	 VBD	O
combined 	combined 	 VBN	O
,  	,  	 ,	O
one  	one  	 CD	O
subject  	subject  	 NN	B-NP
was  	was  	 VBD	O
misclassified  	misclassified  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
cancer  	cancer  	 NN	B-NP
group  	group  	 NN	I-NP
as  	as  	 IN	O
normal  	normal  	 JJ	O
and  	and  	 CC	O
three  	three  	 CD	O
subjects  	subjects  	 NNS	B-NP
were  	were  	 VBD	O
misclassified  	misclassified  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
control  	control  	 NN	B-NP
group  	group  	 NN	I-NP
as  	as  	 IN	O
cancer 	cancer 	 NN	O
.  	.  	 .	O
Thus  	Thus  	 RB	O
for  	for  	 IN	O
this  	this  	 DT	O
rule  	rule  	 NN	O
the  	the  	 DT	O
overall  	overall  	 JJ	O
sensitivity  	sensitivity  	 NN	O
was  	was  	 VBD	O
161 	161 	 CD	O
/ 	/ 	 CD	O
162  	162  	 CD	O
or  	or  	 CC	O
99.4  	99.4  	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
its  	its  	 PRP$	O
overall  	overall  	 JJ	O
specificity  	specificity  	 NN	O
was  	was  	 VBD	O
88 	88 	 CD	O
/ 	/ 	 CD	O
91  	91  	 CD	O
or  	or  	 CC	O
96.7  	96.7  	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
Finally 	Finally 	 RB	O
,  	,  	 ,	O
Rule  	Rule  	 NNP	O
3  	3  	 CD	O
was  	was  	 VBD	O
constructed  	constructed  	 VBN	O
using  	using  	 VBG	O
the  	the  	 DT	O
30  	30  	 CD	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
in  	in  	 IN	O
Rule  	Rule  	 NNP	O
2  	2  	 CD	O
combined  	combined  	 VBN	O
with  	with  	 IN	O
four  	four  	 CD	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
409.75936 	409.75936 	 NNP	O
,  	,  	 ,	O
418.11364 	418.11364 	 NNP	O
,  	,  	 ,	O
435.0751 	435.0751 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
464.3617  	464.3617  	 NNP	O
( 	( 	 -LRB-	O
all  	all  	 DT	O
also  	also  	 RB	O
used  	used  	 VBN	O
in  	in  	 IN	O
Rule  	Rule  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
was  	was  	 VBD	O
done  	done  	 VBN	O
because  	because  	 IN	O
prior  	prior  	 JJ	O
studies  	studies  	 NNS	O
have  	have  	 VBP	O
indicated  	indicated  	 VBN	O
the  	the  	 DT	O
possible  	possible  	 JJ	O
presence  	presence  	 NN	O
of  	of  	 IN	O
low  	low  	 JJ	O
molecular  	molecular  	 JJ	B-NP
weight  	weight  	 NN	I-NP
biomarkers  	biomarkers  	 NN	I-NP
in  	in  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
( 	( 	 -LRB-	O
see  	see  	 VB	O
below 	below 	 IN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
When  	When  	 WRB	O
this  	this  	 DT	O
set  	set  	 NN	O
of  	of  	 IN	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
was  	was  	 VBD	O
subjected  	subjected  	 VBN	O
to  	to  	 TO	O
stepwise  	stepwise  	 VB	O
discriminant  	discriminant  	 JJ	B-NP
analysis 	analysis 	 NN	I-NP
,  	,  	 ,	O
seven  	seven  	 CD	O
variables  	variables  	 NNS	O
at  	at  	 IN	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	O
418.1136 	418.1136 	 NNP	O
,  	,  	 ,	O
435.0751 	435.0751 	 NNP	O
,  	,  	 ,	O
464.3617 	464.3617 	 NNP	O
,  	,  	 ,	O
4003.645 	4003.645 	 NNP	O
,  	,  	 ,	O
4906.962 	4906.962 	 NNP	O
,  	,  	 ,	O
6599.8232 	6599.8232 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
6801.495  	6801.495  	 NNP	O
were  	were  	 VBD	O
retained 	retained 	 VBN	O
.  	.  	 .	O
When  	When  	 WRB	O
Rule  	Rule  	 NNP	O
3  	3  	 CD	O
was  	was  	 VBD	O
applied  	applied  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
entire  	entire  	 JJ	O
data  	data  	 NNS	O
set 	set 	 VBN	O
,  	,  	 ,	O
test  	test  	 NN	O
and  	and  	 CC	O
training  	training  	 NN	O
inclusive 	inclusive 	 NN	O
,  	,  	 ,	O
all  	all  	 DT	O
162  	162  	 CD	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
91  	91  	 CD	O
controls  	controls  	 NNS	O
were  	were  	 VBD	O
appropriately  	appropriately  	 RB	O
categorized  	categorized  	 VBN	O
without  	without  	 IN	O
error  	error  	 NN	O
for  	for  	 IN	O
100 	100 	 CD	O
%  	%  	 NN	O
sensitivity  	sensitivity  	 NN	O
and  	and  	 CC	O
specificity 	specificity 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
actual  	actual  	 JJ	O
classification  	classification  	 JJ	B-NP
schema  	schema  	 NN	I-NP
for  	for  	 IN	O
all  	all  	 DT	O
three  	three  	 CD	O
rules  	rules  	 NNS	O
is  	is  	 VBZ	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Table  	Table  	 NNP	O
3 	3 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
results  	results  	 NNS	O
presented  	presented  	 VBN	O
with  	with  	 IN	O
these  	these  	 DT	O
three  	three  	 CD	O
rules  	rules  	 NNS	O
were  	were  	 VBD	O
all  	all  	 DT	O
achieved  	achieved  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
attempt 	attempt 	 NN	O
.  	.  	 .	O
No  	No  	 DT	O
effort  	effort  	 NN	O
was  	was  	 VBD	O
made  	made  	 VBN	O
to  	to  	 TO	O
further  	further  	 VB	O
optimize  	optimize  	 VBN	O
these  	these  	 DT	O
rules 	rules 	 NNS	O
.  	.  	 .	O
We  	We  	 PRP	O
next  	next  	 IN	B-NP
interchanged  	interchanged  	 VBG	O
the  	the  	 DT	O
test  	test  	 NN	O
and  	and  	 CC	O
training  	training  	 NN	B-NP
sets  	sets  	 NNS	I-NP
and  	and  	 CC	O
used  	used  	 VBD	O
the  	the  	 DT	O
same  	same  	 JJ	O
three  	three  	 CD	O
rule  	rule  	 NN	B-NP
development  	development  	 NN	I-NP
strategies 	strategies 	 NNS	I-NP
.  	.  	 .	O
This  	This  	 DT	O
resulted  	resulted  	 VBN	O
in 	in 	 IN	O
:  	:  	 :	O
1 	1 	 LS	O
)  	)  	 -RRB-	O
Rule  	Rule  	 NNP	O
1  	1  	 CD	O
with  	with  	 IN	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	O
2.8234234 	2.8234234 	 NNP	O
,  	,  	 ,	O
222.41828 	222.41828 	 NNP	O
,  	,  	 ,	O
410.13727 	410.13727 	 NNP	O
,  	,  	 ,	O
417.73207 	417.73207 	 NNP	O
,  	,  	 ,	O
435.07512 	435.07512 	 NNP	O
,  	,  	 ,	O
4027.2999 	4027.2999 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
8035.0581 	8035.0581 	 NNP	O
,  	,  	 ,	O
achieved  	achieved  	 VBD	O
100 	100 	 CD	O
%  	%  	 NN	O
sensitivity  	sensitivity  	 NN	O
and  	and  	 CC	O
specificity  	specificity  	 NN	O
on  	on  	 IN	O
both  	both  	 PDT	O
the  	the  	 DT	O
test  	test  	 NN	O
and  	and  	 CC	O
training  	training  	 NN	B-NP
sets.  	sets.  	 CD	I-NP
2 	2 	 CD	O
)  	)  	 -RRB-	O
Rule  	Rule  	 NNP	O
2  	2  	 CD	O
with  	with  	 IN	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	O
3676.3951 	3676.3951 	 NNP	O
,  	,  	 ,	O
3937.7816 	3937.7816 	 NNP	O
,  	,  	 ,	O
4003.6449 	4003.6449 	 NNP	O
,  	,  	 ,	O
4440.095 	4440.095 	 NNP	O
,  	,  	 ,	O
5269.0367 	5269.0367 	 NNP	O
,  	,  	 ,	O
10511.699 	10511.699 	 NNP	O
,  	,  	 ,	O
14182.82 	14182.82 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
17019.433 	17019.433 	 NNP	O
.  	.  	 .	O
This  	This  	 DT	O
rule  	rule  	 NN	O
achieved  	achieved  	 VBD	O
100 	100 	 CD	O
%  	%  	 NN	O
sensitivity  	sensitivity  	 NN	O
and  	and  	 CC	O
specificity  	specificity  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
training  	training  	 NN	B-NP
set 	set 	 NN	I-NP
.  	.  	 .	O
However  	However  	 RB	O
sensitivity  	sensitivity  	 JJ	O
and  	and  	 CC	O
specificity  	specificity  	 NN	O
fell  	fell  	 VBD	O
on  	on  	 IN	O
the  	the  	 DT	O
test  	test  	 NN	O
set  	set  	 VBN	O
to  	to  	 TO	O
96.25 	96.25 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
91.11 	91.11 	 CD	O
%  	%  	 NN	O
respectively.  	respectively.  	 CD	O
3 	3 	 CD	O
)  	)  	 -RRB-	O
Rule  	Rule  	 NNP	O
3  	3  	 CD	O
with  	with  	 IN	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	O
417.73207 	417.73207 	 NNP	O
,  	,  	 ,	O
435.07512 	435.07512 	 NNP	O
,  	,  	 ,	O
2666.361 	2666.361 	 NNP	O
,  	,  	 ,	O
2674.0769 	2674.0769 	 NNP	O
,  	,  	 ,	O
3937.7816 	3937.7816 	 NNP	O
,  	,  	 ,	O
3991.8435 	3991.8435 	 NNP	O
,  	,  	 ,	O
4821.0481 	4821.0481 	 NNP	O
,  	,  	 ,	O
4839.2088 	4839.2088 	 NNP	O
,  	,  	 ,	O
5269.0367 	5269.0367 	 NNP	O
,  	,  	 ,	O
7627.1183 	7627.1183 	 NNP	O
,  	,  	 ,	O
14182.82 	14182.82 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
17019.433 	17019.433 	 NNP	O
.  	.  	 .	O
This  	This  	 DT	O
rule  	rule  	 NN	O
achieved  	achieved  	 VBD	O
100 	100 	 CD	O
%  	%  	 NN	O
sensitivity  	sensitivity  	 NN	O
and  	and  	 CC	O
specificity  	specificity  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
training  	training  	 NN	B-NP
set 	set 	 NN	I-NP
.  	.  	 .	O
On  	On  	 IN	O
the  	the  	 DT	O
test  	test  	 NN	O
set  	set  	 VBD	O
it  	it  	 PRP	O
achieved  	achieved  	 VBD	O
a  	a  	 DT	O
sensitivity  	sensitivity  	 NN	O
of  	of  	 IN	O
100 	100 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
a  	a  	 DT	O
specificity  	specificity  	 NN	O
of  	of  	 IN	O
97.8 	97.8 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
We  	We  	 PRP	O
have  	have  	 VBP	O
used  	used  	 VBN	O
a  	a  	 DT	O
strategy  	strategy  	 NN	O
identical  	identical  	 NN	O
to  	to  	 TO	O
that  	that  	 DT	O
used  	used  	 VBN	O
in  	in  	 IN	O
Rule  	Rule  	 NNP	O
1  	1  	 CD	O
to  	to  	 TO	O
further  	further  	 RB	O
analyze  	analyze  	 VB	O
this  	this  	 DT	O
data 	data 	 NNS	O
.  	.  	 .	O
First 	First 	 NNP	O
,  	,  	 ,	O
a  	a  	 DT	O
randomly  	randomly  	 RB	O
ordered  	ordered  	 VBN	B-NP
list  	list  	 NN	I-NP
of  	of  	 IN	I-NP
cancer  	cancer  	 NN	I-NP
spectra  	spectra  	 NNS	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
randomly  	randomly  	 RB	O
ordered  	ordered  	 VBN	B-NP
list  	list  	 NN	I-NP
of  	of  	 IN	I-NP
control  	control  	 NN	I-NP
spectra  	spectra  	 NNS	I-NP
were  	were  	 VBD	O
prepared 	prepared 	 VBN	O
.  	.  	 .	O
Next 	Next 	 JJ	O
,  	,  	 ,	O
we  	we  	 PRP	O
assigned  	assigned  	 VBD	O
the  	the  	 DT	O
first  	first  	 JJ	O
20 	20 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
each  	each  	 DT	O
list  	list  	 NN	O
to  	to  	 TO	O
a  	a  	 DT	O
test  	test  	 NN	B-NP
set  	set  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
remaining  	remaining  	 JJ	O
80 	80 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
a  	a  	 DT	O
training  	training  	 NN	B-NP
set 	set 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
process  	process  	 NN	O
was  	was  	 VBD	O
repeated  	repeated  	 VBN	O
five  	five  	 CD	O
times  	times  	 NNS	O
assigning  	assigning  	 VBP	O
the  	the  	 DT	O
next  	next  	 JJ	O
consecutive  	consecutive  	 JJ	O
20 	20 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
each  	each  	 DT	O
list  	list  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
test  	test  	 NN	O
set  	set  	 VBN	O
on  	on  	 IN	O
each  	each  	 DT	O
occasion 	occasion 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
results  	results  	 NNS	O
were  	were  	 VBD	O
very  	very  	 RB	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
those  	those  	 DT	O
above  	above  	 JJ	O
with  	with  	 IN	O
all  	all  	 DT	O
five  	five  	 CD	O
rules  	rules  	 NNS	O
achieving  	achieving  	 VBG	O
100 	100 	 CD	O
%  	%  	 NN	O
sensitivity  	sensitivity  	 NN	O
and  	and  	 CC	O
specificity 	specificity 	 NN	O
.  	.  	 .	O
This  	This  	 DT	O
data  	data  	 NN	O
is  	is  	 VBZ	O
posted  	posted  	 VBN	O
as  	as  	 IN	O
additional  	additional  	 JJ	O
data  	data  	 NNS	O
file  	file  	 VBP	O
Supplement1.xls 	Supplement1.xls 	 CD	B-NP
.  	.  	 .	O
Additional  	Additional  	 JJ	B-NP
File  	File  	 NNP	I-NP
1  	1  	 CD	O
This  	This  	 DT	O
Excel  	Excel  	 NNP	O
file  	file  	 NN	O
contains  	contains  	 VBZ	O
5  	5  	 CD	O
work  	work  	 NN	B-NP
sheets 	sheets 	 NNS	I-NP
.  	.  	 .	O
Each  	Each  	 DT	O
sheet  	sheet  	 NN	O
contains  	contains  	 VBZ	O
the  	the  	 DT	O
most  	most  	 RBS	O
significant  	significant  	 JJ	O
100  	100  	 CD	O
MZ  	MZ  	 NN	B-NP
values  	values  	 NNS	I-NP
from  	from  	 IN	O
a  	a  	 DT	O
training  	training  	 NN	O
set  	set  	 VBD	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
a  	a  	 DT	O
different  	different  	 JJ	O
80 	80 	 CD	O
%  	%  	 NN	O
subset  	subset  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
data 	data 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
MZ  	MZ  	 NNP	B-NP
values  	values  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
sorted  	sorted  	 VBN	O
into  	into  	 IN	O
bins  	bins  	 NN	O
and  	and  	 CC	O
the  	the  	 DT	O
most  	most  	 RBS	O
significant  	significant  	 JJ	O
MZ  	MZ  	 NNP	B-NP
value  	value  	 NN	I-NP
from  	from  	 IN	O
each  	each  	 DT	O
bin  	bin  	 NN	O
( 	( 	 -LRB-	O
marked  	marked  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
"I 	"I 	 NN	O
"  	"  	 ''	O
in  	in  	 IN	O
column  	column  	 NN	B-NP
E 	E 	 NN	I-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
used  	used  	 VBN	O
in  	in  	 IN	O
stepwise  	stepwise  	 JJ	B-NP
dicriminant  	dicriminant  	 JJ	I-NP
analysis 	analysis 	 NN	I-NP
.  	.  	 .	O
MZ  	MZ  	 NNP	B-NP
values  	values  	 VBZ	O
retained  	retained  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
final  	final  	 JJ	B-NP
rule  	rule  	 NN	I-NP
are  	are  	 VBP	O
indicated  	indicated  	 VBN	O
with  	with  	 IN	O
an  	an  	 DT	O
"s 	"s 	 NN	O
"  	"  	 ''	O
in  	in  	 IN	O
column  	column  	 NN	B-NP
F.  	F.  	 NNP	I-NP
Click  	Click  	 NNP	O
here  	here  	 RB	O
for  	for  	 IN	O
file  	file  	 VB	O
The  	The  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
statistically  	statistically  	 JJ	O
significant  	significant  	 JJ	O
signals  	signals  	 NNS	O
at  	at  	 IN	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
less  	less  	 JJR	O
than  	than  	 IN	O
500  	500  	 CD	O
was  	was  	 VBD	O
unexpected  	unexpected  	 JJ	O
as  	as  	 IN	O
some  	some  	 DT	O
investigators 	investigators 	 NNS	B-NP
,  	,  	 ,	O
in  	in  	 IN	O
their  	their  	 PRP$	O
systems 	systems 	 NNS	O
,  	,  	 ,	O
conservatively  	conservatively  	 RB	O
disregard  	disregard  	 JJ	B-NP
data  	data  	 NNS	I-NP
beneath  	beneath  	 IN	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	O
2000  	2000  	 CD	O
as  	as  	 IN	O
possible  	possible  	 JJ	O
noise  	noise  	 NN	O
[  	[  	 -LRB-	O
12  	12  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
To  	To  	 TO	O
further  	further  	 RB	O
investigate  	investigate  	 VB	O
this 	this 	 DT	O
,  	,  	 ,	O
we  	we  	 PRP	O
first  	first  	 RB	O
repeated  	repeated  	 VBN	O
the  	the  	 DT	O
calculation  	calculation  	 NN	O
of  	of  	 IN	O
2-sided  	2-sided  	 NNP	O
Wilcoxon  	Wilcoxon  	 NNP	B-NP
test  	test  	 NN	I-NP
p-values  	p-values  	 NN	I-NP
at  	at  	 IN	O
each  	each  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
15,154  	15,154  	 NNP	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
using  	using  	 VBG	O
the  	the  	 DT	O
entire  	entire  	 JJ	O
data  	data  	 NNS	O
set  	set  	 VBN	O
( 	( 	 -LRB-	O
see  	see  	 VB	O
Figure  	Figure  	 NNP	O
2 	2 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
trends  	trends  	 NNS	O
noted  	noted  	 VBD	O
in  	in  	 IN	O
the  	the  	 DT	O
training  	training  	 NN	B-NP
set  	set  	 NN	I-NP
were  	were  	 VBD	O
present  	present  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
entire  	entire  	 JJ	O
data  	data  	 NNS	O
set 	set 	 VBN	O
,  	,  	 ,	O
although  	although  	 IN	O
with  	with  	 IN	O
increased  	increased  	 JJ	O
statistical  	statistical  	 JJ	B-NP
significance 	significance 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example  	example  	 NN	O
3,591  	3,591  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
15,154  	15,154  	 NNP	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
had  	had  	 VBD	O
mean  	mean  	 JJ	B-NP
intensities  	intensities  	 NN	I-NP
that  	that  	 WDT	O
varied  	varied  	 VBD	O
between  	between  	 IN	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
control  	control  	 NN	O
with  	with  	 IN	O
a  	a  	 DT	O
p-value  	p-value  	 JJ	B-NP
of  	of  	 IN	O
10  	10  	 CD	O
-6or  	-6or  	 CD	O
less 	less 	 JJR	O
.  	.  	 .	O
In  	In  	 IN	O
a  	a  	 DT	O
sample  	sample  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
panel  	panel  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
15,154  	15,154  	 CD	O
independent  	independent  	 JJ	O
random  	random  	 JJ	O
sets  	sets  	 NNS	O
of  	of  	 IN	O
measurements  	measurements  	 JJ	B-NP
split  	split  	 NN	I-NP
between  	between  	 IN	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
control 	control 	 NN	O
,  	,  	 ,	O
using  	using  	 VBG	O
Wilcoxon  	Wilcoxon  	 JJ	B-NP
test  	test  	 NN	I-NP
15,154  	15,154  	 CD	O
times  	times  	 NNS	O
with  	with  	 IN	O
an  	an  	 DT	O
individual  	individual  	 JJ	B-NP
significance  	significance  	 NN	I-NP
level  	level  	 NN	I-NP
of  	of  	 IN	O
10  	10  	 CD	O
-6 	-6 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
false  	false  	 JJ	O
positives  	positives  	 NN	O
is  	is  	 VBZ	O
expected  	expected  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
0.015 	0.015 	 CD	O
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
very  	very  	 RB	O
small 	small 	 JJ	O
.  	.  	 .	O
Alternatively 	Alternatively 	 RB	O
,  	,  	 ,	O
in  	in  	 IN	O
the  	the  	 DT	O
above  	above  	 IN	O
setting  	setting  	 VBG	O
the  	the  	 DT	O
chance  	chance  	 NN	O
that  	that  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
one  	one  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
15,154  	15,154  	 CD	O
measurements  	measurements  	 NNS	B-NP
would  	would  	 MD	O
have  	have  	 VB	O
a  	a  	 DT	O
p-value  	p-value  	 JJ	B-NP
less  	less  	 JJR	O
than  	than  	 IN	O
10  	10  	 CD	O
-6is  	-6is  	 CD	O
approximately  	approximately  	 CD	O
1.5 	1.5 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
Thus  	Thus  	 RB	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
extremely  	extremely  	 RB	O
unlikely  	unlikely  	 JJ	O
that  	that  	 IN	O
a  	a  	 DT	O
false  	false  	 JJ	O
positive  	positive  	 NN	O
would  	would  	 MD	O
occur  	occur  	 VB	O
by  	by  	 IN	O
chance  	chance  	 NN	O
alone  	alone  	 RB	O
in  	in  	 IN	O
a  	a  	 DT	O
15,154  	15,154  	 JJ	O
member  	member  	 NN	O
test  	test  	 NN	O
set 	set 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
finding  	finding  	 NN	O
of  	of  	 IN	O
significant  	significant  	 JJ	O
signals  	signals  	 NNS	O
at  	at  	 IN	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
less  	less  	 JJR	O
than  	than  	 IN	O
500  	500  	 CD	O
is  	is  	 VBZ	O
consistent  	consistent  	 JJ	O
with  	with  	 IN	O
two  	two  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
seven  	seven  	 CD	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
used  	used  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
model  	model  	 NN	B-NP
rule  	rule  	 NN	I-NP
published  	published  	 VBN	O
at  	at  	 IN	O
the  	the  	 DT	O
Clinical  	Clinical  	 NNP	B-NP
Proteomics  	Proteomics  	 NNP	I-NP
Program  	Program  	 NNP	I-NP
Databank  	Databank  	 NNP	I-NP
website  	website  	 NN	I-NP
that  	that  	 WDT	O
was  	was  	 VBD	O
developed  	developed  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
data  	data  	 NNS	O
set  	set  	 VBN	O
( 	( 	 -LRB-	O
see  	see  	 VB	O
Table  	Table  	 NNP	O
4 	4 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
specifically  	specifically  	 RB	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
435.46452  	435.46452  	 NNP	O
( 	( 	 -LRB-	O
p-value  	p-value  	 NNP	B-NP
=  	=  	 SYM	O
9.08  	9.08  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
-372  	-372  	 CD	O
ndmost  	ndmost  	 CD	B-NP
significant  	significant  	 JJ	O
of  	of  	 IN	O
9  	9  	 CD	O
values  	values  	 NNS	O
in  	in  	 IN	O
its  	its  	 PRP$	O
bin 	bin 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
465.56916  	465.56916  	 NNP	O
( 	( 	 -LRB-	O
p-value  	p-value  	 NNP	B-NP
=  	=  	 SYM	O
2.50  	2.50  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
-286  	-286  	 CD	O
thmost  	thmost  	 CD	B-NP
significant  	significant  	 JJ	O
of  	of  	 IN	O
the  	the  	 DT	O
7  	7  	 CD	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
found  	found  	 VBN	O
in  	in  	 IN	O
its  	its  	 PRP$	O
bin 	bin 	 NN	O
)  	)  	 -RRB-	O
[  	[  	 -LRB-	O
7  	7  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
values  	values  	 NNS	O
correspond  	correspond  	 VBP	O
to  	to  	 TO	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	O
435.0751  	435.0751  	 NNP	O
and  	and  	 CC	O
464.3617  	464.3617  	 RB	O
used  	used  	 VBN	O
in  	in  	 IN	O
Rule  	Rule  	 NNP	O
1 	1 	 CD	O
.  	.  	 .	O
As  	As  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Figure  	Figure  	 NNP	O
3 	3 	 CD	O
,  	,  	 ,	O
each  	each  	 DT	O
of  	of  	 IN	O
these  	these  	 DT	O
two  	two  	 CD	O
pairs  	pairs  	 NNS	O
of  	of  	 IN	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
are  	are  	 VBP	O
surprisingly  	surprisingly  	 RB	O
effective  	effective  	 JJ	O
at  	at  	 IN	O
separating  	separating  	 VBG	O
the  	the  	 DT	O
162  	162  	 CD	O
cancer  	cancer  	 NN	B-NP
subjects  	subjects  	 NNS	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
91  	91  	 CD	O
control  	control  	 NN	B-NP
subjects  	subjects  	 NNS	I-NP
with  	with  	 IN	O
an  	an  	 DT	O
advantage  	advantage  	 NN	O
noted  	noted  	 VBD	O
with  	with  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
pair  	pair  	 NN	O
( 	( 	 -LRB-	O
compare  	compare  	 VB	O
panel  	panel  	 NN	O
A  	A  	 NN	O
with  	with  	 IN	O
B 	B 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Even  	Even  	 RB	O
more  	more  	 RBR	O
interesting  	interesting  	 JJ	O
is  	is  	 VBZ	O
the  	the  	 DT	O
finding  	finding  	 NN	O
that  	that  	 IN	O
significant  	significant  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
found  	found  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
Rule  	Rule  	 NNP	O
1  	1  	 CD	O
included  	included  	 VBD	O
the  	the  	 DT	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	O
2.7921478  	2.7921478  	 NNP	O
and  	and  	 CC	O
245.53704 	245.53704 	 NNP	O
.  	.  	 .	O
As  	As  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Figure  	Figure  	 NNP	O
3 	3 	 CD	O
,  	,  	 ,	O
panel  	panel  	 NN	O
C 	C 	 NNP	O
,  	,  	 ,	O
these  	these  	 DT	O
two  	two  	 CD	O
values  	values  	 NNS	O
can  	can  	 MD	O
also  	also  	 RB	O
significantly  	significantly  	 RB	O
separate  	separate  	 VB	O
the  	the  	 DT	O
162  	162  	 CD	O
cancer  	cancer  	 NN	B-NP
subjects  	subjects  	 NNS	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
91  	91  	 CD	O
control  	control  	 NN	B-NP
subjects 	subjects 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
interpretation  	interpretation  	 NN	B-NP
of  	of  	 IN	O
these  	these  	 DT	O
values  	values  	 NNS	O
is  	is  	 VBZ	O
problematic 	problematic 	 JJ	O
,  	,  	 ,	O
given  	given  	 VBN	O
the  	the  	 DT	O
low  	low  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
involved 	involved 	 VBN	O
.  	.  	 .	O
In  	In  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
these  	these  	 DT	O
findings 	findings 	 NNS	O
,  	,  	 ,	O
we  	we  	 PRP	O
first  	first  	 RB	O
investigated  	investigated  	 VBN	O
whether  	whether  	 IN	O
data  	data  	 NNS	O
normalization  	normalization  	 VBP	O
as  	as  	 RB	O
described  	described  	 VBN	O
at  	at  	 IN	O
the  	the  	 DT	O
Clinical  	Clinical  	 NNP	B-NP
Proteomics  	Proteomics  	 NNP	I-NP
Data  	Data  	 NNP	I-NP
Bank  	Bank  	 NNP	I-NP
[  	[  	 -LRB-	O
5  	5  	 LS	O
]  	]  	 -RRB-	O
could  	could  	 MD	O
influence  	influence  	 VB	O
the  	the  	 DT	O
Wilcoxon  	Wilcoxon  	 JJ	B-NP
test  	test  	 NN	I-NP
p-values  	p-values  	 NN	I-NP
found  	found  	 VBD	O
using  	using  	 VBG	O
the  	the  	 DT	O
raw  	raw  	 JJ	O
data  	data  	 NNS	O
( 	( 	 -LRB-	O
see  	see  	 VB	O
methods 	methods 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Several  	Several  	 JJ	O
points  	points  	 NNS	O
were  	were  	 VBD	O
chosen 	chosen 	 VBN	O
,  	,  	 ,	O
and  	and  	 CC	O
no  	no  	 DT	O
effect  	effect  	 NN	O
was  	was  	 VBD	O
noted  	noted  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
p-values  	p-values  	 JJ	B-NP
( 	( 	 -LRB-	O
see  	see  	 VB	O
Table  	Table  	 NNP	O
5 	5 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
We  	We  	 PRP	O
further  	further  	 RB	O
analyzed  	analyzed  	 VBD	O
several  	several  	 JJ	O
selected  	selected  	 JJ	O
low  	low  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values 	values 	 NNS	I-NP
,  	,  	 ,	O
less  	less  	 JJR	O
than  	than  	 IN	O
500 	500 	 CD	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
process 	process 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
control  	control  	 NN	B-NP
data  	data  	 NNS	I-NP
were  	were  	 VBD	O
pooled 	pooled 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
pooled  	pooled  	 JJ	O
data  	data  	 NNS	O
were  	were  	 VBD	O
randomly  	randomly  	 RB	O
partitioned  	partitioned  	 VBN	O
between  	between  	 IN	O
a  	a  	 DT	O
set  	set  	 VBN	O
containing  	containing  	 VBG	O
91  	91  	 CD	O
members  	members  	 NNS	O
and  	and  	 CC	O
a  	a  	 DT	O
set  	set  	 VBN	O
containing  	containing  	 VBG	O
162  	162  	 CD	O
members 	members 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
Wilcoxon  	Wilcoxon  	 JJ	B-NP
test  	test  	 NN	I-NP
was  	was  	 VBD	O
then  	then  	 RB	O
run  	run  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
randomized  	randomized  	 JJ	B-NP
set 	set 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
process  	process  	 NN	O
was  	was  	 VBD	O
repeated  	repeated  	 VBN	O
10,000  	10,000  	 CD	O
times 	times 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
lowest  	lowest  	 JJS	O
p-values  	p-values  	 NN	B-NP
were  	were  	 VBD	O
chosen 	chosen 	 VBN	O
.  	.  	 .	O
As  	As  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Table  	Table  	 NNP	O
5 	5 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
lowest  	lowest  	 JJS	O
p-values  	p-values  	 JJ	B-NP
generated  	generated  	 NN	I-NP
by  	by  	 IN	O
the  	the  	 DT	O
permutation  	permutation  	 JJ	B-NP
process  	process  	 NN	I-NP
were  	were  	 VBD	O
on  	on  	 IN	O
the  	the  	 DT	O
order  	order  	 NN	O
of  	of  	 IN	O
0.0001 	0.0001 	 NNP	O
,  	,  	 ,	O
as  	as  	 RB	O
expected  	expected  	 VBN	O
given  	given  	 VBN	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
permutations  	permutations  	 JJ	B-NP
tested 	tested 	 NN	O
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
highly  	highly  	 RB	O
unlikely  	unlikely  	 JJ	O
that  	that  	 IN	O
either  	either  	 DT	O
data  	data  	 NN	O
normalization  	normalization  	 NNS	O
or  	or  	 CC	O
a  	a  	 DT	O
chance  	chance  	 NN	B-NP
distribution  	distribution  	 NN	I-NP
could  	could  	 MD	O
have  	have  	 VB	O
accounted  	accounted  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
highly  	highly  	 RB	O
significant  	significant  	 JJ	O
p-values  	p-values  	 NN	B-NP
noted  	noted  	 VBD	O
in  	in  	 IN	O
the  	the  	 DT	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
region  	region  	 NN	I-NP
less  	less  	 RBR	O
than  	than  	 IN	O
500 	500 	 CD	O
.  	.  	 .	O
Finally 	Finally 	 RB	O
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
interesting  	interesting  	 JJ	O
to  	to  	 TO	O
note  	note  	 VB	O
that  	that  	 IN	O
the  	the  	 DT	O
remaining  	remaining  	 JJ	O
five  	five  	 CD	O
values  	values  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
Clinical  	Clinical  	 NNP	B-NP
Proteomics  	Proteomics  	 NNP	I-NP
Program  	Program  	 NNP	I-NP
Databank  	Databank  	 NNP	I-NP
model  	model  	 NN	I-NP
rule  	rule  	 NN	I-NP
all  	all  	 RB	O
have  	have  	 VB	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
greater  	greater  	 JJR	O
than  	than  	 IN	O
2000  	2000  	 CD	O
and  	and  	 CC	O
relatively  	relatively  	 RB	O
high  	high  	 JJ	O
p-values 	p-values 	 NN	B-NP
.  	.  	 .	O
Specifically  	Specifically  	 RB	O
the  	the  	 DT	O
remaining  	remaining  	 JJ	O
values  	values  	 NNS	O
are  	are  	 VBP	O
( 	( 	 -LRB-	O
note  	note  	 NN	O
that  	that  	 IN	O
the  	the  	 DT	O
p-values  	p-values  	 NNS	B-NP
are  	are  	 VBP	O
calculated  	calculated  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
entire  	entire  	 JJ	O
data  	data  	 NNS	O
set 	set 	 VBN	O
) 	) 	 -RRB-	O
:  	:  	 :	O
1 	1 	 LS	O
)  	)  	 -RRB-	O
M 	M 	 NNP	O
/ 	/ 	 NNP	O
Z  	Z  	 NNP	O
=  	=  	 SYM	O
2760.6685 	2760.6685 	 CD	O
,  	,  	 ,	O
p  	p  	 VBG	O
=  	=  	 SYM	O
0.24  	0.24  	 CD	O
2 	2 	 CD	O
)  	)  	 -RRB-	O
M 	M 	 NNP	O
/ 	/ 	 NNP	O
Z  	Z  	 NNP	O
=  	=  	 SYM	O
19643.409 	19643.409 	 CD	O
,  	,  	 ,	O
p  	p  	 VBG	O
=  	=  	 SYM	O
0.52  	0.52  	 CD	O
3 	3 	 CD	O
)  	)  	 -RRB-	O
M 	M 	 NNP	O
/ 	/ 	 NNP	O
Z  	Z  	 NNP	O
=  	=  	 SYM	O
6631.7043 	6631.7043 	 CD	O
,  	,  	 ,	O
p  	p  	 VBG	O
=  	=  	 SYM	O
9.0  	9.0  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
-4  	-4  	 CD	O
4 	4 	 CD	O
)  	)  	 -RRB-	O
M 	M 	 NNP	O
/ 	/ 	 NNP	O
Z  	Z  	 NNP	O
=  	=  	 SYM	O
14051.976 	14051.976 	 CD	O
,  	,  	 ,	O
p  	p  	 VBG	O
=  	=  	 SYM	O
1.8  	1.8  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
-8  	-8  	 CD	O
5 	5 	 CD	O
)  	)  	 -RRB-	O
M 	M 	 NNP	O
/ 	/ 	 NNP	O
Z  	Z  	 NNP	O
=  	=  	 SYM	O
3497.5508 	3497.5508 	 CD	O
,  	,  	 ,	O
p  	p  	 VBG	O
=  	=  	 SYM	O
1.4  	1.4  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
-6  	-6  	 CD	O
By  	By  	 IN	O
contrast  	contrast  	 NN	O
all  	all  	 PDT	O
the  	the  	 DT	O
M 	M 	 NNP	O
/ 	/ 	 NNP	O
Z  	Z  	 NNP	O
values  	values  	 VBZ	O
used  	used  	 VBN	O
in  	in  	 IN	O
Rule  	Rule  	 NNP	O
1  	1  	 CD	O
have  	have  	 VBP	O
p-values  	p-values  	 JJ	O
less  	less  	 JJR	O
than  	than  	 IN	O
10  	10  	 CD	O
-26 	-26 	 CD	O
( 	( 	 -LRB-	O
compare  	compare  	 VB	O
Table  	Table  	 NNP	O
1with  	1with  	 NNP	O
Table  	Table  	 NNP	O
4 	4 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
There  	There  	 EX	O
are  	are  	 VBP	O
several  	several  	 JJ	O
non-exclusive  	non-exclusive  	 JJ	B-NP
explanations  	explanations  	 NNS	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
significant  	significant  	 JJ	O
P-values  	P-values  	 NN	B-NP
in  	in  	 IN	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
region  	region  	 NN	I-NP
less  	less  	 RBR	O
than  	than  	 IN	O
500 	500 	 CD	O
.  	.  	 .	O
First 	First 	 NNP	O
,  	,  	 ,	O
these  	these  	 DT	O
may  	may  	 MD	O
actually  	actually  	 RB	O
represent  	represent  	 VB	O
biomarkers  	biomarkers  	 VBN	O
that  	that  	 IN	O
correlate  	correlate  	 NN	O
with  	with  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer 	cancer 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
disease  	disease  	 NN	B-NP
process  	process  	 NN	I-NP
may  	may  	 MD	O
influence  	influence  	 VB	O
the  	the  	 DT	O
serum  	serum  	 JJ	B-NP
concentration  	concentration  	 NN	I-NP
of  	of  	 IN	I-NP
lipids 	lipids 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
other  	other  	 JJ	O
small  	small  	 JJ	O
molecules  	molecules  	 NNS	O
that  	that  	 IN	O
either  	either  	 DT	O
bind  	bind  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
chip  	chip  	 NN	O
directly  	directly  	 RB	O
or  	or  	 CC	O
through  	through  	 IN	O
a  	a  	 DT	O
complex  	complex  	 JJ	O
formation  	formation  	 NN	O
with  	with  	 IN	O
other  	other  	 JJ	O
macromolecules  	macromolecules  	 NNS	B-NP
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
binding  	binding  	 VBG	O
to  	to  	 TO	O
a  	a  	 DT	O
receptor 	receptor 	 NN	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
lysophospholipids  	lysophospholipids  	 NNS	B-NP
represent  	represent  	 VBP	O
a  	a  	 DT	O
class  	class  	 NN	O
of  	of  	 IN	O
compounds  	compounds  	 NNS	O
that  	that  	 WDT	O
have  	have  	 VBP	O
an  	an  	 DT	O
important  	important  	 JJ	O
role  	role  	 NN	O
in  	in  	 IN	O
extracellular  	extracellular  	 JJ	B-NP
signaling 	signaling 	 NN	I-NP
.  	.  	 .	O
Lysophophatidic  	Lysophophatidic  	 NNP	B-NP
Acid  	Acid  	 NNP	I-NP
( 	( 	 -LRB-	O
LPA 	LPA 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
a  	a  	 DT	O
member  	member  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
class  	class  	 NN	O
of  	of  	 IN	O
compounds 	compounds 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
its  	its  	 PRP$	O
plasma  	plasma  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
proposed  	proposed  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
potential  	potential  	 JJ	B-NP
biomarker  	biomarker  	 NN	I-NP
for  	for  	 IN	I-NP
ovarian  	ovarian  	 JJ	I-NP
cancer  	cancer  	 NN	I-NP
[  	[  	 -LRB-	O
16  	16  	 CD	O
17  	17  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
LPA  	LPA  	 NNP	B-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
family  	family  	 NN	O
of  	of  	 IN	O
related  	related  	 JJ	O
molecules  	molecules  	 NNS	O
with  	with  	 IN	O
molecular  	molecular  	 JJ	B-NP
weights  	weights  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
vicinity  	vicinity  	 NN	O
of  	of  	 IN	O
400  	400  	 CD	O
to  	to  	 TO	O
600  	600  	 CD	O
Daltons 	Daltons 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
variety  	variety  	 NN	O
of  	of  	 IN	O
LPA  	LPA  	 NNP	B-NP
species  	species  	 NN	I-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
reported  	reported  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
increased  	increased  	 VBN	O
in  	in  	 IN	O
malignant  	malignant  	 JJ	B-NP
ascites  	ascites  	 NN	I-NP
from  	from  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
as  	as  	 IN	O
detected  	detected  	 VBN	O
by  	by  	 IN	O
electrospray  	electrospray  	 FW	B-NP
ionization  	ionization  	 FW	I-NP
mass  	mass  	 FW	I-NP
spectrometry  	spectrometry  	 FW	I-NP
( 	( 	 -LRB-	O
ESI-MS 	ESI-MS 	 NNP	B-NP
)  	)  	 -RRB-	O
[  	[  	 -LRB-	O
18  	18  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
LPA  	LPA  	 NNP	B-NP
related  	related  	 JJ	O
species  	species  	 NNS	B-NP
have  	have  	 VBP	O
also  	also  	 RB	O
been  	been  	 VBN	O
reported  	reported  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
increased  	increased  	 VBN	O
in  	in  	 IN	O
plasma  	plasma  	 JJ	B-NP
samples  	samples  	 NNS	I-NP
from  	from  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
using  	using  	 VBG	O
a  	a  	 DT	O
combination  	combination  	 NN	O
of  	of  	 IN	O
thin  	thin  	 JJ	O
layer  	layer  	 NN	B-NP
chromatography  	chromatography  	 NNS	I-NP
( 	( 	 -LRB-	O
to  	to  	 TO	O
isolate  	isolate  	 VB	O
an  	an  	 DT	O
"LPA  	"LPA  	 JJ	O
band 	band 	 NN	O
"  	"  	 ''	O
from  	from  	 IN	O
patient  	patient  	 JJ	O
plasma 	plasma 	 NN	B-NP
)  	)  	 -RRB-	O
followed  	followed  	 VBD	O
by  	by  	 IN	O
ESI-MS 	ESI-MS 	 JJ	B-NP
.  	.  	 .	O
This  	This  	 DT	O
study  	study  	 NN	O
reported  	reported  	 VBD	O
significant  	significant  	 JJ	O
LPA  	LPA  	 NN	B-NP
increases  	increases  	 NNS	I-NP
in  	in  	 IN	O
cancer  	cancer  	 NN	B-NP
samples  	samples  	 NNS	I-NP
with  	with  	 IN	O
increased  	increased  	 JJ	O
intensities  	intensities  	 NN	O
noted  	noted  	 VBD	O
at  	at  	 IN	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	O
409 	409 	 CD	O
,  	,  	 ,	O
433-437 	433-437 	 NNP	O
,  	,  	 ,	O
457 	457 	 CD	O
,  	,  	 ,	O
481-482 	481-482 	 NNP	O
,  	,  	 ,	O
571 	571 	 CD	O
,  	,  	 ,	O
599 	599 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
619 	619 	 CD	O
.  	.  	 .	O
This  	This  	 DT	O
report  	report  	 NN	O
also  	also  	 RB	O
reviews  	reviews  	 VBZ	O
the  	the  	 DT	O
evidence  	evidence  	 NN	O
that  	that  	 IN	O
these  	these  	 DT	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
are  	are  	 VBP	O
consistent  	consistent  	 JJ	O
with  	with  	 IN	O
LPA  	LPA  	 NNP	B-NP
family  	family  	 NN	I-NP
members  	members  	 NNS	I-NP
[  	[  	 -LRB-	O
19  	19  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Figure  	Figure  	 NN	O
4shows  	4shows  	 VBZ	O
the  	the  	 DT	O
average  	average  	 JJ	O
intensities  	intensities  	 NN	O
and  	and  	 CC	O
p-values  	p-values  	 JJ	B-NP
for  	for  	 IN	O
both  	both  	 PDT	O
the  	the  	 DT	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
control  	control  	 NN	B-NP
groups  	groups  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
region  	region  	 NN	O
between  	between  	 IN	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	O
410  	410  	 CD	O
to  	to  	 TO	O
470 	470 	 CD	O
.  	.  	 .	O
Among  	Among  	 IN	O
other  	other  	 JJ	O
features 	features 	 NNS	O
,  	,  	 ,	O
an  	an  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
mean  	mean  	 JJ	B-NP
intensity  	intensity  	 NN	I-NP
for  	for  	 IN	O
cancers  	cancers  	 NNS	O
at  	at  	 IN	O
a  	a  	 DT	O
peak  	peak  	 NN	O
centered  	centered  	 VBN	O
at  	at  	 IN	O
an  	an  	 DT	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
of  	of  	 IN	O
459  	459  	 CD	O
is  	is  	 VBZ	O
noted 	noted 	 VBN	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
also  	also  	 RB	O
of  	of  	 IN	O
note  	note  	 NN	O
in  	in  	 IN	O
this  	this  	 DT	O
region  	region  	 NN	O
are 	are 	 VBP	O
:  	:  	 :	O
1 	1 	 LS	O
)  	)  	 -RRB-	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
=  	=  	 SYM	O
464.3617  	464.3617  	 CD	O
with  	with  	 IN	O
a  	a  	 DT	O
p-value  	p-value  	 JJ	B-NP
less  	less  	 JJR	O
than  	than  	 IN	O
6.8  	6.8  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
-35 	-35 	 CD	O
,  	,  	 ,	O
that  	that  	 WDT	O
correlates  	correlates  	 VBZ	O
with  	with  	 IN	O
a  	a  	 DT	O
shoulder  	shoulder  	 NN	O
in  	in  	 IN	O
a  	a  	 DT	O
secondary  	secondary  	 JJ	B-NP
peak  	peak  	 NN	I-NP
at  	at  	 IN	O
about  	about  	 IN	O
463 	463 	 CD	O
,  	,  	 ,	O
that  	that  	 WDT	O
is  	is  	 VBZ	O
decreased  	decreased  	 VBN	O
in  	in  	 IN	O
cancer  	cancer  	 NN	B-NP
patients  	patients  	 NNS	I-NP
( 	( 	 -LRB-	O
average  	average  	 JJ	O
intensity  	intensity  	 NN	O
17.5  	17.5  	 CD	O
for  	for  	 IN	O
cancer  	cancer  	 NN	O
versus  	versus  	 IN	O
23.6  	23.6  	 CD	O
for  	for  	 IN	O
controls 	controls 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
2 	2 	 LS	O
)  	)  	 -RRB-	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
=  	=  	 SYM	O
435.0751  	435.0751  	 CD	O
with  	with  	 IN	O
a  	a  	 DT	O
p-value  	p-value  	 JJ	B-NP
of  	of  	 IN	O
less  	less  	 JJR	O
than  	than  	 IN	O
3.9  	3.9  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
-37 	-37 	 CD	O
,  	,  	 ,	O
that  	that  	 WDT	O
corresponds  	corresponds  	 VBZ	O
to  	to  	 TO	O
a  	a  	 DT	O
peak  	peak  	 NN	O
with  	with  	 IN	O
increased  	increased  	 JJ	O
intensity  	intensity  	 NN	O
in  	in  	 IN	O
cancer  	cancer  	 NN	O
( 	( 	 -LRB-	O
average  	average  	 JJ	O
intensity  	intensity  	 NN	O
33  	33  	 CD	O
for  	for  	 IN	O
cancer  	cancer  	 NN	O
versus  	versus  	 IN	O
25.5  	25.5  	 CD	O
for  	for  	 IN	O
controls 	controls 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
3 	3 	 LS	O
)  	)  	 -RRB-	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
=  	=  	 SYM	O
417.73207  	417.73207  	 CD	O
with  	with  	 IN	O
a  	a  	 DT	O
p-value  	p-value  	 JJ	B-NP
less  	less  	 JJR	O
than  	than  	 IN	O
6.2  	6.2  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
-35 	-35 	 CD	O
,  	,  	 ,	O
that  	that  	 WDT	O
corresponds  	corresponds  	 VBZ	O
to  	to  	 TO	O
a  	a  	 DT	O
peak  	peak  	 NN	O
that  	that  	 WDT	O
is  	is  	 VBZ	O
decreased  	decreased  	 VBN	O
in  	in  	 IN	O
cancer  	cancer  	 NN	O
( 	( 	 -LRB-	O
average  	average  	 JJ	O
intensity  	intensity  	 NN	O
39.5  	39.5  	 CD	O
for  	for  	 IN	O
cancer  	cancer  	 NN	O
versus  	versus  	 IN	O
47.4  	47.4  	 CD	O
for  	for  	 IN	O
controls 	controls 	 NNS	O
)  	)  	 -RRB-	O
The  	The  	 DT	O
identity  	identity  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
molecules  	molecules  	 JJ	O
responsible  	responsible  	 JJ	O
for  	for  	 IN	O
these  	these  	 DT	O
differences  	differences  	 NNS	O
cannot  	cannot  	 RB	O
be  	be  	 VB	O
determined  	determined  	 VBN	O
from  	from  	 IN	O
this  	this  	 DT	O
data 	data 	 NNS	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
possible  	possible  	 JJ	O
that  	that  	 IN	O
in  	in  	 IN	O
some  	some  	 DT	O
cases  	cases  	 NNS	O
they  	they  	 PRP	O
may  	may  	 MD	O
relate  	relate  	 VB	O
to  	to  	 TO	O
the  	the  	 DT	O
LPA  	LPA  	 NNP	B-NP
family  	family  	 NN	I-NP
of  	of  	 IN	O
molecules 	molecules 	 NNS	O
,  	,  	 ,	O
or  	or  	 CC	O
to  	to  	 TO	O
alterations  	alterations  	 VB	O
in  	in  	 IN	O
proteins  	proteins  	 NNS	O
that  	that  	 IN	O
bind  	bind  	 JJ	B-NP
LPA  	LPA  	 NNP	I-NP
family  	family  	 NN	I-NP
members 	members 	 NNS	I-NP
.  	.  	 .	O
Other  	Other  	 JJ	O
explanations  	explanations  	 NNS	O
for  	for  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
statistically  	statistically  	 JJ	O
significant  	significant  	 JJ	O
bands  	bands  	 NNS	O
of  	of  	 IN	O
low  	low  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
include  	include  	 VBP	O
degradation  	degradation  	 JJ	B-NP
products  	products  	 NNS	I-NP
of  	of  	 IN	O
higher  	higher  	 JJR	O
molecular  	molecular  	 JJ	B-NP
weight  	weight  	 NN	I-NP
macromolecules  	macromolecules  	 NNS	I-NP
or  	or  	 CC	O
a  	a  	 DT	O
matrix  	matrix  	 JJ	B-NP
effect 	effect 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
if  	if  	 IN	O
a  	a  	 DT	O
set  	set  	 NN	O
of  	of  	 IN	O
proteins  	proteins  	 NNS	O
exist  	exist  	 VBP	O
that  	that  	 WDT	O
are  	are  	 VBP	O
expressed  	expressed  	 VBN	O
at  	at  	 IN	O
different  	different  	 JJ	O
levels  	levels  	 NNS	O
between  	between  	 IN	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
control  	control  	 NN	B-NP
subjects  	subjects  	 NNS	I-NP
but  	but  	 CC	O
have  	have  	 VB	O
a  	a  	 DT	O
common  	common  	 JJ	O
domain 	domain 	 NN	O
,  	,  	 ,	O
then  	then  	 RB	O
a  	a  	 DT	O
common  	common  	 JJ	O
product  	product  	 NN	B-NP
ion  	ion  	 NN	I-NP
of  	of  	 IN	O
lower  	lower  	 JJR	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
generated  	generated  	 VBN	O
that  	that  	 WDT	O
would  	would  	 MD	O
represent  	represent  	 VB	O
a  	a  	 DT	O
summation  	summation  	 NN	O
of  	of  	 IN	O
all  	all  	 PDT	O
the  	the  	 DT	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
expression  	expression  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
group  	group  	 NN	O
of  	of  	 IN	O
proteins 	proteins 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
might  	might  	 MD	O
thus  	thus  	 RB	O
have  	have  	 VB	O
greater  	greater  	 JJR	O
statistical  	statistical  	 JJ	B-NP
significance  	significance  	 NN	I-NP
than  	than  	 IN	O
the  	the  	 DT	O
changes  	changes  	 NNS	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
any  	any  	 DT	O
single  	single  	 JJ	O
high  	high  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
value 	value 	 NN	I-NP
.  	.  	 .	O
Similarly 	Similarly 	 RB	O
,  	,  	 ,	O
a  	a  	 DT	O
set  	set  	 NN	O
of  	of  	 IN	O
low  	low  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
molecules  	molecules  	 NNS	I-NP
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
energy-absorbing  	energy-absorbing  	 JJ	B-NP
molecule  	molecule  	 NN	I-NP
or  	or  	 CC	O
matrix 	matrix 	 CD	B-NP
)  	)  	 -RRB-	O
that  	that  	 WDT	O
interacts  	interacts  	 VBP	O
differently  	differently  	 RB	O
in  	in  	 IN	O
a  	a  	 DT	O
protein  	protein  	 NN	B-NP
environment  	environment  	 NN	I-NP
that  	that  	 WDT	O
differs  	differs  	 VBZ	O
markedly  	markedly  	 RB	O
between  	between  	 IN	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
control  	control  	 NN	O
could  	could  	 MD	O
hypothetically  	hypothetically  	 RB	O
generate  	generate  	 VB	O
a  	a  	 DT	O
similar  	similar  	 JJ	O
phenomenon 	phenomenon 	 NN	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
difficult  	difficult  	 JJ	O
to  	to  	 TO	O
apply  	apply  	 VB	O
any  	any  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
above  	above  	 JJ	O
explanations  	explanations  	 NNS	B-NP
to  	to  	 TO	O
the  	the  	 DT	O
very  	very  	 RB	O
low  	low  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
such  	such  	 JJ	O
as  	as  	 IN	O
2.7921478  	2.7921478  	 NNP	O
and  	and  	 CC	O
245.53704 	245.53704 	 NNP	O
,  	,  	 ,	O
although  	although  	 IN	O
in  	in  	 IN	O
the  	the  	 DT	O
last  	last  	 JJ	O
case  	case  	 NN	O
an  	an  	 DT	O
extremely  	extremely  	 RB	O
small  	small  	 JJ	O
organic  	organic  	 JJ	B-NP
molecule  	molecule  	 NN	I-NP
is  	is  	 VBZ	O
possible 	possible 	 JJ	O
.  	.  	 .	O
Alternatively 	Alternatively 	 RB	O
,  	,  	 ,	O
there  	there  	 EX	O
maybe  	maybe  	 RB	O
some  	some  	 DT	O
unexpected  	unexpected  	 JJ	O
experimental  	experimental  	 JJ	B-NP
bias  	bias  	 NN	I-NP
or  	or  	 CC	O
systematic  	systematic  	 JJ	B-NP
error  	error  	 NN	I-NP
that  	that  	 IN	O
accounts  	accounts  	 NNS	O
for  	for  	 IN	O
low  	low  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
discrimination 	discrimination 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
could  	could  	 MD	O
occur  	occur  	 VB	O
at  	at  	 IN	O
any  	any  	 DT	O
experimental  	experimental  	 JJ	B-NP
step 	step 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
might  	might  	 MD	O
include  	include  	 VB	O
medication  	medication  	 NN	O
or  	or  	 CC	O
lifestyle  	lifestyle  	 JJ	B-NP
change  	change  	 NN	I-NP
that  	that  	 WDT	O
occurs  	occurs  	 VBZ	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
learn  	learn  	 VBP	O
they  	they  	 PRP	O
have  	have  	 VBP	O
a  	a  	 DT	O
cancer  	cancer  	 NN	B-NP
diagnosis 	diagnosis 	 NN	I-NP
,  	,  	 ,	O
variation  	variation  	 NN	O
in  	in  	 IN	O
sample  	sample  	 NN	O
collection 	collection 	 NN	O
,  	,  	 ,	O
processing  	processing  	 NN	O
and  	and  	 CC	O
preservation 	preservation 	 NN	B-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
bias  	bias  	 NN	O
introduced  	introduced  	 VBN	O
at  	at  	 IN	O
the  	the  	 DT	O
time  	time  	 NN	O
of  	of  	 IN	O
analysis 	analysis 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
case  	case  	 NN	O
of  	of  	 IN	O
LPA 	LPA 	 NNP	B-NP
,  	,  	 ,	O
increased  	increased  	 VBD	O
plasma  	plasma  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
platelet  	platelet  	 JJ	B-NP
activation 	activation 	 NN	I-NP
.  	.  	 .	O
Another  	Another  	 DT	O
group  	group  	 NN	O
trying  	trying  	 VBG	O
to  	to  	 TO	O
repeat  	repeat  	 VB	O
the  	the  	 DT	O
observations  	observations  	 NNS	B-NP
of  	of  	 IN	O
increased  	increased  	 JJ	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
LPA  	LPA  	 NNP	B-NP
associated  	associated  	 VBN	O
with  	with  	 IN	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
concluded  	concluded  	 VBD	O
that  	that  	 IN	O
there  	there  	 EX	O
was  	was  	 VBD	O
no  	no  	 DT	O
diagnostic  	diagnostic  	 JJ	B-NP
value  	value  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
assay 	assay 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
attributed  	attributed  	 VBD	O
the  	the  	 DT	O
discrepant  	discrepant  	 JJ	B-NP
findings  	findings  	 NNS	I-NP
as  	as  	 IN	O
possibly  	possibly  	 RB	O
related  	related  	 VBN	O
to  	to  	 TO	O
different  	different  	 JJ	O
sample  	sample  	 NN	B-NP
centrifugation  	centrifugation  	 NNS	I-NP
protocols  	protocols  	 VBP	I-NP
used  	used  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
two  	two  	 CD	O
groups  	groups  	 NNS	O
to  	to  	 TO	O
remove  	remove  	 VB	O
platelets  	platelets  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
samples  	samples  	 NNS	O
prior  	prior  	 RB	O
to  	to  	 TO	O
analysis  	analysis  	 NN	O
[  	[  	 -LRB-	O
20  	20  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
LPA  	LPA  	 NNP	B-NP
continues  	continues  	 VBZ	O
to  	to  	 TO	O
be  	be  	 VB	O
actively  	actively  	 RB	O
evaluated  	evaluated  	 VBN	O
for  	for  	 IN	O
its  	its  	 PRP$	O
clinical  	clinical  	 JJ	B-NP
utility  	utility  	 NN	I-NP
[  	[  	 -LRB-	O
21  	21  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Conclusions  	Conclusions  	 FW	O
Serum  	Serum  	 FW	B-NP
proteomic  	proteomic  	 FW	I-NP
profiling  	profiling  	 FW	O
is  	is  	 VBZ	O
a  	a  	 DT	O
new  	new  	 JJ	O
approach  	approach  	 NN	O
to  	to  	 TO	O
cancer  	cancer  	 NN	B-NP
diagnosis 	diagnosis 	 NN	I-NP
.  	.  	 .	O
However  	However  	 RB	O
it  	it  	 PRP	O
confronts  	confronts  	 VBZ	O
a  	a  	 DT	O
challenging  	challenging  	 JJ	O
environment 	environment 	 NN	O
,  	,  	 ,	O
as  	as  	 IN	O
it  	it  	 PRP	O
combines  	combines  	 VBZ	O
measurement  	measurement  	 JJ	B-NP
technologies  	technologies  	 NNS	I-NP
that  	that  	 WDT	O
are  	are  	 VBP	O
new  	new  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	B-NP
setting  	setting  	 NN	I-NP
with  	with  	 IN	O
novel  	novel  	 NN	O
approaches  	approaches  	 NNS	O
to  	to  	 TO	O
processing  	processing  	 NN	O
and  	and  	 CC	O
interpreting  	interpreting  	 VBG	O
high  	high  	 JJ	O
dimensional  	dimensional  	 JJ	B-NP
data 	data 	 NNS	I-NP
.  	.  	 .	O
Further 	Further 	 RB	O
,  	,  	 ,	O
controlling  	controlling  	 VBG	O
large  	large  	 JJ	O
clinical  	clinical  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
can  	can  	 MD	O
be  	be  	 VB	O
challenging  	challenging  	 VBG	O
even  	even  	 RB	O
in  	in  	 IN	O
more  	more  	 RBR	O
established  	established  	 JJ	O
settings 	settings 	 NNS	O
.  	.  	 .	O
Nevertheless 	Nevertheless 	 RB	O
,  	,  	 ,	O
it  	it  	 PRP	O
represents  	represents  	 VBZ	O
an  	an  	 DT	O
advance  	advance  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
diagnose  	diagnose  	 VB	O
and  	and  	 CC	O
understand  	understand  	 VB	O
illness 	illness 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
results  	results  	 NNS	O
presented  	presented  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
are  	are  	 VBP	O
useful  	useful  	 JJ	O
for  	for  	 IN	O
several  	several  	 JJ	O
reasons 	reasons 	 NNS	O
.  	.  	 .	O
First 	First 	 NNP	O
,  	,  	 ,	O
in  	in  	 IN	O
regard  	regard  	 NN	O
to  	to  	 TO	O
disease  	disease  	 NN	B-NP
classification 	classification 	 NN	I-NP
,  	,  	 ,	O
advanced  	advanced  	 JJ	O
data  	data  	 NN	O
mining  	mining  	 NN	O
techniques  	techniques  	 NNS	O
should  	should  	 MD	O
be  	be  	 VB	O
benchmarked  	benchmarked  	 VBN	O
against  	against  	 IN	O
traditional  	traditional  	 JJ	O
methods  	methods  	 NNS	O
when  	when  	 WRB	O
possible 	possible 	 JJ	O
.  	.  	 .	O
Further  	Further  	 RBR	O
identical  	identical  	 JJ	O
training  	training  	 NN	B-NP
sets  	sets  	 NNS	I-NP
should  	should  	 MD	O
be  	be  	 VB	O
defined  	defined  	 VBN	O
for  	for  	 IN	O
such  	such  	 PDT	O
a  	a  	 DT	O
comparison  	comparison  	 NN	O
as  	as  	 IN	O
results  	results  	 NNS	O
may  	may  	 MD	O
very  	very  	 RB	O
depending  	depending  	 VBG	O
on  	on  	 IN	O
the  	the  	 DT	O
samples  	samples  	 NNS	O
chosen  	chosen  	 VBN	O
for  	for  	 IN	O
inclusion  	inclusion  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
training  	training  	 NN	B-NP
set 	set 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
disease  	disease  	 NN	O
classifiers  	classifiers  	 VBZ	O
using  	using  	 VBG	O
routine  	routine  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
proved  	proved  	 VBD	O
to  	to  	 TO	O
be  	be  	 VB	O
straightforward 	straightforward 	 JJ	O
,  	,  	 ,	O
and  	and  	 CC	O
resulted  	resulted  	 VBD	O
in  	in  	 IN	O
excellent  	excellent  	 JJ	O
performance  	performance  	 NN	O
in  	in  	 IN	O
both  	both  	 PDT	O
the  	the  	 DT	O
test  	test  	 NN	O
and  	and  	 CC	O
training  	training  	 NN	B-NP
sets  	sets  	 NNS	I-NP
( 	( 	 -LRB-	O
e.g.  	e.g.  	 CD	O
100 	100 	 CD	O
%  	%  	 NN	O
sensitivity  	sensitivity  	 NN	O
and  	and  	 CC	O
specificity  	specificity  	 NN	O
for  	for  	 IN	O
Rules  	Rules  	 NNP	O
1  	1  	 CD	O
and  	and  	 CC	O
3  	3  	 CD	O
in  	in  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
training  	training  	 NN	B-NP
set 	set 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
particular  	particular  	 JJ	O
these  	these  	 DT	O
preliminary  	preliminary  	 JJ	B-NP
data  	data  	 NNS	I-NP
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
these  	these  	 DT	O
two  	two  	 CD	O
rules  	rules  	 NNS	O
may  	may  	 MD	O
be  	be  	 VB	O
specific  	specific  	 JJ	O
enough  	enough  	 JJ	O
to  	to  	 TO	O
scale  	scale  	 VB	O
to  	to  	 TO	O
larger  	larger  	 JJR	O
population  	population  	 NN	B-NP
trials  	trials  	 NNS	I-NP
without  	without  	 IN	O
generating  	generating  	 VBG	O
an  	an  	 DT	O
unacceptably  	unacceptably  	 JJ	O
high  	high  	 JJ	O
false  	false  	 JJ	O
positive  	positive  	 JJ	B-NP
rate 	rate 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
study  	study  	 NN	O
also  	also  	 RB	O
confirms  	confirms  	 VBZ	O
that  	that  	 IN	O
a  	a  	 DT	O
classifier  	classifier  	 NN	B-NP
could  	could  	 MD	O
be  	be  	 VB	O
developed  	developed  	 VBN	O
with  	with  	 IN	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
greater  	greater  	 JJR	O
than  	than  	 IN	O
2000 	2000 	 CD	O
.  	.  	 .	O
This  	This  	 DT	O
indicates  	indicates  	 VBZ	O
that  	that  	 DT	O
information  	information  	 NN	O
regarding  	regarding  	 VBG	O
the  	the  	 DT	O
difference  	difference  	 NN	O
between  	between  	 IN	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
control  	control  	 NN	O
is  	is  	 VBZ	O
present  	present  	 JJ	O
throughout  	throughout  	 IN	O
the  	the  	 DT	O
entire  	entire  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
region  	region  	 NN	I-NP
studied 	studied 	 VBD	O
,  	,  	 ,	O
a  	a  	 DT	O
result  	result  	 NN	O
entirely  	entirely  	 RB	O
consistent  	consistent  	 JJ	O
with  	with  	 IN	O
the  	the  	 DT	O
observed  	observed  	 JJ	O
Wilcoxon  	Wilcoxon  	 JJ	B-NP
test  	test  	 NN	I-NP
p-values 	p-values 	 NN	I-NP
.  	.  	 .	O
Secondly 	Secondly 	 RB	O
,  	,  	 ,	O
routine  	routine  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
allows  	allows  	 VBZ	O
investigators  	investigators  	 NNS	B-NP
to  	to  	 TO	O
rapidly  	rapidly  	 RB	O
review  	review  	 VB	O
the  	the  	 DT	O
data  	data  	 NNS	O
for  	for  	 IN	O
their  	their  	 PRP$	O
general  	general  	 JJ	O
trends 	trends 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
correlate  	correlate  	 VBG	O
the  	the  	 DT	O
findings  	findings  	 NNS	O
with  	with  	 IN	O
other  	other  	 JJ	O
information 	information 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
findings  	findings  	 NNS	O
of  	of  	 IN	O
significant  	significant  	 JJ	O
discrimination  	discrimination  	 NN	B-NP
between  	between  	 IN	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
control  	control  	 NN	B-NP
groups  	groups  	 NNS	I-NP
at  	at  	 IN	O
low  	low  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
indicates  	indicates  	 VBZ	O
that  	that  	 DT	O
attention  	attention  	 NN	O
should  	should  	 MD	O
be  	be  	 VB	O
focused  	focused  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
region 	region 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
particular 	particular 	 JJ	O
,  	,  	 ,	O
if  	if  	 IN	O
experimental  	experimental  	 JJ	B-NP
bias  	bias  	 NN	I-NP
and  	and  	 CC	O
noise  	noise  	 NN	B-NP
effects  	effects  	 NNS	I-NP
can  	can  	 MD	O
be  	be  	 VB	O
excluded 	excluded 	 VBN	O
,  	,  	 ,	O
this  	this  	 DT	O
region  	region  	 NN	O
may  	may  	 MD	O
prove  	prove  	 VB	O
to  	to  	 TO	O
offer  	offer  	 VB	O
the  	the  	 DT	O
optimum  	optimum  	 NN	B-NP
for  	for  	 IN	I-NP
ovarian  	ovarian  	 JJ	I-NP
cancer  	cancer  	 NN	I-NP
diagnostic  	diagnostic  	 JJ	I-NP
test  	test  	 NN	I-NP
development 	development 	 NN	I-NP
.  	.  	 .	O
On  	On  	 IN	O
the  	the  	 DT	O
other  	other  	 JJ	O
hand 	hand 	 NN	O
,  	,  	 ,	O
if  	if  	 IN	O
bias  	bias  	 NN	O
cannot  	cannot  	 RB	O
be  	be  	 VB	O
excluded 	excluded 	 VBN	O
,  	,  	 ,	O
the  	the  	 DT	O
possibility  	possibility  	 NN	O
must  	must  	 MD	O
be  	be  	 VB	O
entertained  	entertained  	 VBN	O
that  	that  	 IN	O
higher  	higher  	 JJR	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
may  	may  	 MD	O
also  	also  	 RB	O
have  	have  	 VBP	O
been  	been  	 VBN	O
similarly  	similarly  	 RB	O
affected 	affected 	 VBN	O
.  	.  	 .	O
In  	In  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
address  	address  	 VB	O
these  	these  	 DT	O
issues 	issues 	 NNS	O
,  	,  	 ,	O
consideration  	consideration  	 NN	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
given  	given  	 VBN	O
to  	to  	 TO	O
using  	using  	 VBG	O
mass  	mass  	 JJ	O
spectrometry  	spectrometry  	 JJ	B-NP
methods  	methods  	 NNS	I-NP
with  	with  	 IN	O
increased  	increased  	 JJ	O
sensitivity  	sensitivity  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
low  	low  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
region 	region 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
experimental  	experimental  	 JJ	B-NP
conditions  	conditions  	 NNS	I-NP
used  	used  	 VBN	O
to  	to  	 TO	O
physically  	physically  	 VB	O
bind  	bind  	 VBN	O
the  	the  	 DT	O
serum  	serum  	 JJ	B-NP
samples  	samples  	 NNS	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
chip  	chip  	 NN	O
prior  	prior  	 RB	O
to  	to  	 TO	O
analysis  	analysis  	 NN	O
may  	may  	 MD	O
also  	also  	 RB	O
prove  	prove  	 VB	O
critical 	critical 	 JJ	O
,  	,  	 ,	O
and  	and  	 CC	O
should  	should  	 MD	O
be  	be  	 VB	O
consistent  	consistent  	 JJ	O
with  	with  	 IN	O
those  	those  	 DT	O
used  	used  	 VBN	O
in  	in  	 IN	O
collecting  	collecting  	 VBG	O
the  	the  	 DT	O
current  	current  	 JJ	O
data  	data  	 NNS	O
set 	set 	 VBN	O
.  	.  	 .	O
Also 	Also 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
possibility  	possibility  	 NN	O
that  	that  	 IN	O
the  	the  	 DT	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
low  	low  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
region  	region  	 NN	I-NP
may  	may  	 MD	O
represent  	represent  	 VB	O
an  	an  	 DT	O
additive  	additive  	 JJ	B-NP
effect  	effect  	 NN	I-NP
caused  	caused  	 VBN	O
by  	by  	 IN	O
differing  	differing  	 VBG	B-NP
protein  	protein  	 NN	I-NP
environments  	environments  	 NNS	I-NP
between  	between  	 IN	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
normal  	normal  	 JJ	O
may  	may  	 MD	O
be  	be  	 VB	O
approached  	approached  	 VBN	O
by  	by  	 IN	O
intentionally  	intentionally  	 RB	O
spiking  	spiking  	 JJ	O
samples  	samples  	 NNS	O
with  	with  	 IN	O
panels  	panels  	 NNS	O
of  	of  	 IN	O
known  	known  	 JJ	O
proteins 	proteins 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
determining  	determining  	 VBG	O
if  	if  	 IN	O
there  	there  	 EX	O
is  	is  	 VBZ	O
an  	an  	 DT	O
effect  	effect  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
spectra  	spectra  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
low  	low  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
region 	region 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
internal  	internal  	 JJ	B-NP
standards  	standards  	 NNS	I-NP
to  	to  	 TO	O
normalize  	normalize  	 VB	O
this  	this  	 DT	O
type  	type  	 NN	O
of  	of  	 IN	O
experimental  	experimental  	 JJ	B-NP
system  	system  	 NN	I-NP
in  	in  	 IN	O
general  	general  	 NN	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
considered 	considered 	 VBN	O
.  	.  	 .	O
As  	As  	 RB	O
with  	with  	 IN	O
all  	all  	 DT	O
clinical  	clinical  	 JJ	B-NP
test  	test  	 NN	I-NP
development 	development 	 NN	I-NP
,  	,  	 ,	O
confirmation  	confirmation  	 NN	B-NP
of  	of  	 IN	O
results  	results  	 NNS	O
in  	in  	 IN	O
independent  	independent  	 JJ	O
laboratories  	laboratories  	 NNS	O
running  	running  	 VBG	O
blinded  	blinded  	 JJ	O
samples  	samples  	 NNS	O
will  	will  	 MD	O
remain  	remain  	 VB	O
the  	the  	 DT	O
gold  	gold  	 NN	O
standard  	standard  	 NN	O
in  	in  	 IN	O
ruling  	ruling  	 VBG	O
out  	out  	 RP	O
the  	the  	 DT	O
possible  	possible  	 JJ	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
bias 	bias 	 NN	O
,  	,  	 ,	O
unless  	unless  	 IN	O
the  	the  	 DT	O
sample  	sample  	 NN	O
set  	set  	 VBD	O
itself  	itself  	 PRP	O
contains  	contains  	 VBZ	O
the  	the  	 DT	O
bias 	bias 	 NN	O
.  	.  	 .	O
Particular  	Particular  	 JJ	B-NP
attention  	attention  	 NN	I-NP
should  	should  	 MD	O
be  	be  	 VB	O
paid  	paid  	 VBN	O
to  	to  	 TO	O
pre-analytic  	pre-analytic  	 JJ	B-NP
causes  	causes  	 NNS	I-NP
of  	of  	 IN	O
bias  	bias  	 NN	O
that  	that  	 WDT	O
may  	may  	 MD	O
influence  	influence  	 VB	O
the  	the  	 DT	O
serum  	serum  	 JJ	B-NP
proteome 	proteome 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
particular  	particular  	 JJ	O
the  	the  	 DT	O
coagulation  	coagulation  	 NN	B-NP
and  	and  	 CC	O
complement  	complement  	 JJ	B-NP
systems  	systems  	 NNS	I-NP
should  	should  	 MD	O
be  	be  	 VB	O
considered  	considered  	 VBN	O
as  	as  	 IN	O
potential  	potential  	 JJ	B-NP
sources  	sources  	 NNS	I-NP
of  	of  	 IN	O
noise  	noise  	 NN	O
in  	in  	 IN	O
this  	this  	 DT	O
context 	context 	 NN	O
,  	,  	 ,	O
as  	as  	 IN	O
both  	both  	 DT	O
are  	are  	 VBP	O
activated  	activated  	 VBN	O
during  	during  	 IN	O
serum  	serum  	 JJ	B-NP
sample  	sample  	 NN	I-NP
collection  	collection  	 NN	I-NP
and  	and  	 CC	O
generate  	generate  	 VB	O
low  	low  	 JJ	O
molecular  	molecular  	 JJ	B-NP
weight  	weight  	 NN	I-NP
products 	products 	 NNS	I-NP
.  	.  	 .	O
These  	These  	 DT	O
products  	products  	 NNS	O
are  	are  	 VBP	O
undesirable  	undesirable  	 VBN	O
for  	for  	 IN	O
two  	two  	 CD	O
reasons 	reasons 	 NNS	O
.  	.  	 .	O
First 	First 	 NNP	O
,  	,  	 ,	O
if  	if  	 IN	O
a  	a  	 DT	O
putative  	putative  	 JJ	B-NP
tumor  	tumor  	 NN	I-NP
biomarker  	biomarker  	 NNS	I-NP
( 	( 	 -LRB-	O
e.g.  	e.g.  	 NNP	O
LPA 	LPA 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
a  	a  	 DT	O
member  	member  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
pathway  	pathway  	 NN	O
altered  	altered  	 VBN	O
during  	during  	 IN	O
serum  	serum  	 JJ	B-NP
sample  	sample  	 NN	I-NP
collection 	collection 	 NN	I-NP
,  	,  	 ,	O
changes  	changes  	 NNS	O
between  	between  	 IN	O
plasma  	plasma  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
control  	control  	 NN	B-NP
subjects  	subjects  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
obscured 	obscured 	 NNS	O
.  	.  	 .	O
Secondly 	Secondly 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
generation  	generation  	 NN	O
of  	of  	 IN	O
activation  	activation  	 JJ	B-NP
products  	products  	 NNS	I-NP
may  	may  	 MD	O
simply  	simply  	 RB	O
complicate  	complicate  	 VB	O
the  	the  	 DT	O
spectrum 	spectrum 	 NN	B-NP
.  	.  	 .	O
Also 	Also 	 RB	O
,  	,  	 ,	O
sample  	sample  	 NN	O
collection  	collection  	 NN	O
practices  	practices  	 NNS	O
should  	should  	 MD	O
be  	be  	 VB	O
rigorously  	rigorously  	 RB	O
defined 	defined 	 VBN	O
,  	,  	 ,	O
and  	and  	 CC	O
include  	include  	 VBP	O
submitting  	submitting  	 VBG	O
matched  	matched  	 VBN	B-NP
control  	control  	 NN	I-NP
and  	and  	 CC	O
cancer  	cancer  	 NN	B-NP
samples  	samples  	 NNS	I-NP
from  	from  	 IN	O
all  	all  	 DT	O
centers  	centers  	 NNS	O
participating  	participating  	 VBG	O
in  	in  	 IN	O
the  	the  	 DT	O
study 	study 	 NN	O
.  	.  	 .	O
Matching  	Matching  	 VBG	O
for  	for  	 IN	O
age  	age  	 NN	O
and  	and  	 CC	O
menopausal  	menopausal  	 JJ	B-NP
status  	status  	 NN	I-NP
should  	should  	 MD	O
be  	be  	 VB	O
considered 	considered 	 VBN	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
in  	in  	 IN	O
the  	the  	 DT	O
data  	data  	 NNS	O
set  	set  	 VBD	O
used  	used  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
study 	study 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
mean  	mean  	 JJ	B-NP
age  	age  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
control  	control  	 NN	I-NP
group  	group  	 NN	I-NP
was  	was  	 VBD	O
47  	47  	 CD	O
years  	years  	 NNS	O
and  	and  	 CC	O
the  	the  	 DT	O
cancer  	cancer  	 NN	B-NP
group  	group  	 NN	I-NP
60  	60  	 CD	O
years 	years 	 NNS	O
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
noteworthy  	noteworthy  	 VBN	O
that  	that  	 IN	O
the  	the  	 DT	O
average  	average  	 JJ	O
age  	age  	 NN	O
of  	of  	 IN	O
menopause  	menopause  	 NN	O
is  	is  	 VBZ	O
approximately  	approximately  	 RB	O
51  	51  	 CD	O
years  	years  	 NNS	O
[  	[  	 -LRB-	O
22  	22  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
may  	may  	 MD	O
introduce  	introduce  	 VB	O
a  	a  	 DT	O
bias  	bias  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
results  	results  	 NNS	O
reported  	reported  	 VBD	O
in  	in  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
all  	all  	 DT	O
others  	others  	 NNS	O
derived  	derived  	 VBN	O
from  	from  	 IN	O
this  	this  	 DT	O
dataset 	dataset 	 NN	B-NP
.  	.  	 .	O
Finally 	Finally 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
steps  	steps  	 NNS	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
sample  	sample  	 NN	O
collection 	collection 	 NN	O
,  	,  	 ,	O
processing 	processing 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
binding  	binding  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
chip  	chip  	 NN	O
may  	may  	 MD	O
represent  	represent  	 VB	O
a  	a  	 DT	O
particularly  	particularly  	 RB	O
fertile  	fertile  	 JJ	O
area  	area  	 NN	O
for  	for  	 IN	O
research 	research 	 NN	O
.  	.  	 .	O
Any  	Any  	 DT	O
combination  	combination  	 NN	O
of  	of  	 IN	O
such  	such  	 JJ	O
steps  	steps  	 NNS	O
may  	may  	 MD	O
significantly  	significantly  	 RB	O
alter  	alter  	 VB	O
the  	the  	 DT	O
molecular  	molecular  	 JJ	B-NP
subset  	subset  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
sample  	sample  	 NN	O
that  	that  	 WDT	O
can  	can  	 MD	O
be  	be  	 VB	O
successfully  	successfully  	 RB	O
analyzed 	analyzed 	 VBD	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
discriminate  	discriminate  	 VB	O
between  	between  	 IN	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
control  	control  	 VB	O
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	O
2.79  	2.79  	 CD	O
and  	and  	 CC	O
245.5  	245.5  	 NNP	O
reveals  	reveals  	 VBZ	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
experimental  	experimental  	 JJ	B-NP
bias  	bias  	 NN	I-NP
not  	not  	 RB	O
related  	related  	 VBN	O
to  	to  	 TO	O
disease  	disease  	 NN	B-NP
pathology 	pathology 	 NN	I-NP
,  	,  	 ,	O
that  	that  	 WDT	O
likely  	likely  	 RB	O
involves  	involves  	 VBZ	O
machine  	machine  	 NN	B-NP
noise  	noise  	 NN	I-NP
and  	and  	 CC	O
matrix  	matrix  	 JJ	B-NP
effects 	effects 	 NNS	I-NP
.  	.  	 .	O
This  	This  	 DT	O
is  	is  	 VBZ	O
particularly  	particularly  	 RB	O
true  	true  	 JJ	O
of  	of  	 IN	O
the  	the  	 DT	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
value  	value  	 NN	I-NP
at  	at  	 IN	O
2.79  	2.79  	 CD	O
which  	which  	 WDT	O
represents  	represents  	 VBZ	O
a  	a  	 DT	O
bias  	bias  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
mass  	mass  	 JJ	O
spectrometer  	spectrometer  	 JJ	B-NP
instrument  	instrument  	 NN	I-NP
itself 	itself 	 PRP	O
.  	.  	 .	O
If  	If  	 IN	O
this  	this  	 DT	O
is  	is  	 VBZ	O
the  	the  	 DT	O
case  	case  	 NN	O
the  	the  	 DT	O
higher  	higher  	 JJR	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
regions  	regions  	 NNS	I-NP
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
affected 	affected 	 VBN	O
.  	.  	 .	O
These  	These  	 DT	O
findings  	findings  	 NNS	O
indicate  	indicate  	 VBP	O
that  	that  	 IN	O
any  	any  	 DT	O
rule  	rule  	 NN	O
derived  	derived  	 VBN	O
from  	from  	 IN	O
this  	this  	 DT	O
data  	data  	 NNS	O
set 	set 	 VBN	O
,  	,  	 ,	O
including  	including  	 VBG	O
the  	the  	 DT	O
ones  	ones  	 NNS	B-NP
presented  	presented  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
paper 	paper 	 NN	O
,  	,  	 ,	O
may  	may  	 MD	O
be  	be  	 VB	O
detecting  	detecting  	 JJ	O
differences  	differences  	 NNS	O
in  	in  	 IN	O
experimental  	experimental  	 JJ	B-NP
bias  	bias  	 NN	I-NP
and  	and  	 CC	O
not  	not  	 RB	O
disease  	disease  	 JJ	B-NP
pathology 	pathology 	 NN	I-NP
.  	.  	 .	O
Investigators  	Investigators  	 NNS	B-NP
in  	in  	 IN	O
this  	this  	 DT	O
field  	field  	 NN	O
may  	may  	 MD	O
minimize  	minimize  	 VB	O
their  	their  	 PRP$	O
chances  	chances  	 NNS	O
of  	of  	 IN	O
false  	false  	 JJ	O
discovery  	discovery  	 NN	O
by  	by  	 IN	O
careful  	careful  	 JJ	O
experimental  	experimental  	 JJ	O
design  	design  	 NN	O
and  	and  	 CC	O
by  	by  	 IN	O
using  	using  	 VBG	O
routine  	routine  	 JJ	B-NP
statistical  	statistical  	 JJ	I-NP
methods  	methods  	 NNS	I-NP
to  	to  	 TO	O
both  	both  	 DT	O
overview  	overview  	 NN	B-NP
the  	the  	 DT	O
data  	data  	 NNS	O
( 	( 	 -LRB-	O
in  	in  	 IN	O
an  	an  	 DT	O
intentional  	intentional  	 JJ	B-NP
search  	search  	 NN	I-NP
for  	for  	 IN	O
bias 	bias 	 NN	O
)  	)  	 -RRB-	O
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
a  	a  	 DT	O
benchmark  	benchmark  	 NN	O
for  	for  	 IN	O
comparison  	comparison  	 NN	O
with  	with  	 IN	O
other  	other  	 JJ	O
data  	data  	 NN	B-NP
mining  	mining  	 NN	I-NP
algorithms 	algorithms 	 NN	I-NP
.  	.  	 .	O
Methods  	Methods  	 NNS	O
A  	A  	 DT	O
training  	training  	 NN	B-NP
set  	set  	 NN	I-NP
was  	was  	 VBD	O
formed  	formed  	 VBN	O
by  	by  	 IN	O
randomly  	randomly  	 RB	O
sampling  	sampling  	 CD	O
45  	45  	 CD	O
spectra  	spectra  	 NNS	O
out  	out  	 RP	O
of  	of  	 IN	O
the  	the  	 DT	O
91  	91  	 CD	O
controls  	controls  	 NNS	O
and  	and  	 CC	O
80  	80  	 CD	O
spectra  	spectra  	 NNS	O
out  	out  	 RP	O
of  	of  	 IN	O
the  	the  	 DT	O
162  	162  	 CD	O
cancer  	cancer  	 NN	B-NP
cases  	cases  	 NNS	I-NP
( 	( 	 -LRB-	O
see  	see  	 VB	O
Figure  	Figure  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Those  	Those  	 DT	O
spectra  	spectra  	 NN	O
that  	that  	 WDT	O
were  	were  	 VBD	O
in  	in  	 IN	O
the  	the  	 DT	O
original  	original  	 JJ	B-NP
data  	data  	 NNS	I-NP
set  	set  	 VBN	O
but  	but  	 CC	O
not  	not  	 RB	O
in  	in  	 IN	O
the  	the  	 DT	O
training  	training  	 NN	B-NP
set  	set  	 NN	I-NP
were  	were  	 VBD	O
considered  	considered  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
' 	' 	 POS	O
test 	test 	 NN	O
'  	'  	 POS	O
set 	set 	 NN	O
.  	.  	 .	O
Two-sided  	Two-sided  	 NNP	O
Wilcoxon  	Wilcoxon  	 NNP	B-NP
test  	test  	 NN	I-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
compare  	compare  	 VB	O
the  	the  	 DT	O
intensity  	intensity  	 NN	O
between  	between  	 IN	O
the  	the  	 DT	O
controls  	controls  	 NNS	O
and  	and  	 CC	O
cancers  	cancers  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
training  	training  	 NN	O
set  	set  	 VBN	O
at  	at  	 IN	O
each  	each  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
15,154  	15,154  	 NNP	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values 	values 	 NNS	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
then  	then  	 RB	O
selected  	selected  	 VBN	O
a  	a  	 DT	O
subset  	subset  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
M 	M 	 NNP	I-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
lowest  	lowest  	 JJS	O
Wilcoxon  	Wilcoxon  	 JJ	B-NP
test  	test  	 NN	I-NP
p-values  	p-values  	 NNS	I-NP
( 	( 	 -LRB-	O
see  	see  	 VB	O
the  	the  	 DT	O
Results  	Results  	 NNS	O
section  	section  	 NN	O
for  	for  	 IN	O
details 	details 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
We  	We  	 PRP	O
sorted  	sorted  	 VBD	O
on  	on  	 IN	O
consecutive  	consecutive  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 VBZ	O
to  	to  	 TO	O
get  	get  	 VB	O
bins 	bins 	 NNS	O
.  	.  	 .	O
A  	A  	 DT	O
separation  	separation  	 NN	O
of  	of  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
one  	one  	 CD	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
value  	value  	 NN	I-NP
was  	was  	 VBD	O
required  	required  	 VBN	O
to  	to  	 TO	O
start  	start  	 VB	O
the  	the  	 DT	O
next  	next  	 JJ	O
bin 	bin 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
lowest  	lowest  	 JJS	O
p-value  	p-value  	 JJ	B-NP
in  	in  	 IN	O
each  	each  	 DT	O
bin  	bin  	 NN	O
was  	was  	 VBD	O
selected  	selected  	 VBN	O
and  	and  	 CC	O
the  	the  	 DT	O
corresponding  	corresponding  	 JJ	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
value  	value  	 NN	I-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
in  	in  	 IN	O
stepwise  	stepwise  	 JJ	B-NP
discriminant  	discriminant  	 JJ	I-NP
analysis  	analysis  	 NN	I-NP
to  	to  	 TO	O
determine  	determine  	 VB	O
the  	the  	 DT	O
subset  	subset  	 NN	B-NP
of  	of  	 IN	I-NP
M 	M 	 NNP	I-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
values  	values  	 NNS	I-NP
that  	that  	 IN	O
best  	best  	 JJS	O
discriminated  	discriminated  	 JJ	O
cancer  	cancer  	 NN	O
from  	from  	 IN	O
control  	control  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
training  	training  	 NN	B-NP
set 	set 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
criteria  	criteria  	 NNS	O
were  	were  	 VBD	O
applied  	applied  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
test  	test  	 NN	B-NP
data  	data  	 NNS	I-NP
set 	set 	 VBN	O
,  	,  	 ,	O
and  	and  	 CC	O
sensitivity  	sensitivity  	 NN	O
and  	and  	 CC	O
specificity  	specificity  	 NN	O
were  	were  	 VBD	O
computed 	computed 	 VBN	O
.  	.  	 .	O
All  	All  	 PDT	O
the  	the  	 DT	O
analyses  	analyses  	 NNS	O
were  	were  	 VBD	O
performed  	performed  	 VBN	O
in  	in  	 IN	O
SAS  	SAS  	 NNP	B-NP
Version  	Version  	 NNP	I-NP
8.2  	8.2  	 CD	O
( 	( 	 -LRB-	O
A  	A  	 DT	O
statistical  	statistical  	 JJ	B-NP
package  	package  	 NN	I-NP
from  	from  	 IN	O
SAS  	SAS  	 NNP	O
Institute  	Institute  	 NNP	O
Inc. 	Inc. 	 NNP	O
,  	,  	 ,	O
Cary 	Cary 	 NNP	O
,  	,  	 ,	O
NC 	NC 	 NNP	B-NP
,  	,  	 ,	O
USA 	USA 	 NNP	B-NP
)  	)  	 -RRB-	O
on  	on  	 IN	O
a  	a  	 DT	O
personal  	personal  	 JJ	B-NP
computer 	computer 	 NN	I-NP
.  	.  	 .	O
Wilcoxon  	Wilcoxon  	 JJ	B-NP
test  	test  	 NN	I-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
using  	using  	 VBG	O
NPAR1WAY  	NPAR1WAY  	 CD	O
procedure  	procedure  	 NN	O
in  	in  	 IN	O
SAS 	SAS 	 NNP	B-NP
,  	,  	 ,	O
stepwise  	stepwise  	 JJ	B-NP
discriminant  	discriminant  	 JJ	I-NP
analysis  	analysis  	 NN	I-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
using  	using  	 VBG	O
STEPDISC  	STEPDISC  	 NNP	B-NP
procedure  	procedure  	 NN	I-NP
in  	in  	 IN	O
SAS 	SAS 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
discriminant  	discriminant  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
using  	using  	 VBG	O
DISCRIM  	DISCRIM  	 NNP	B-NP
procedure  	procedure  	 NN	I-NP
in  	in  	 IN	O
SAS  	SAS  	 NNP	B-NP
[  	[  	 -LRB-	O
23  	23  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
To  	To  	 TO	O
normalize  	normalize  	 VB	O
the  	the  	 DT	O
data 	data 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
procedure  	procedure  	 NN	O
outlined  	outlined  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
Clinical  	Clinical  	 NNP	B-NP
Proteomics  	Proteomics  	 NNP	I-NP
Program  	Program  	 NNP	I-NP
Databank  	Databank  	 NNP	I-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
[  	[  	 -LRB-	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
control  	control  	 NN	B-NP
values  	values  	 NNS	I-NP
for  	for  	 IN	O
each  	each  	 DT	O
M 	M 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Z  	Z  	 NNP	I-NP
were  	were  	 VBD	O
given  	given  	 VBN	O
respective  	respective  	 JJ	O
labels 	labels 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
data  	data  	 NNS	O
were  	were  	 VBD	O
then  	then  	 RB	O
pooled  	pooled  	 VBN	O
and  	and  	 CC	O
normalized  	normalized  	 VBP	O
using  	using  	 VBG	O
the  	the  	 DT	O
formula  	formula  	 NN	B-NP
NV  	NV  	 NNP	I-NP
=  	=  	 NNP	O
( 	( 	 -LRB-	O
V-Min 	V-Min 	 NNP	B-NP
) 	) 	 -RRB-	O
/ 	/ 	 NNP	O
( 	( 	 -LRB-	O
Max  	Max  	 NNP	O
-  	-  	 :	O
Min 	Min 	 LS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
expression 	expression 	 NN	O
,  	,  	 ,	O
Min  	Min  	 NNP	O
is  	is  	 VBZ	O
the  	the  	 DT	O
minimum  	minimum  	 JJ	O
intensity  	intensity  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
pooled  	pooled  	 JJ	O
samples 	samples 	 NNS	O
,  	,  	 ,	O
Max  	Max  	 NNP	O
represents  	represents  	 VBZ	O
the  	the  	 DT	O
maximum  	maximum  	 JJ	B-NP
intensity  	intensity  	 NN	I-NP
found  	found  	 VBD	O
in  	in  	 IN	O
the  	the  	 DT	O
pooled  	pooled  	 JJ	O
samples 	samples 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
NV  	NV  	 NNP	B-NP
represents  	represents  	 VBZ	O
the  	the  	 DT	O
normalized  	normalized  	 JJ	O
value 	value 	 NN	O
.  	.  	 .	O
Using  	Using  	 VBG	O
this  	this  	 DT	O
procedure 	procedure 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
data  	data  	 NN	O
intensities  	intensities  	 NNS	O
will  	will  	 MD	O
all  	all  	 RB	O
fall  	fall  	 VB	O
between  	between  	 IN	O
0  	0  	 CD	O
and  	and  	 CC	O
1 	1 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
data  	data  	 NN	O
points  	points  	 NNS	O
were  	were  	 VBD	O
sorted  	sorted  	 VBN	O
into  	into  	 IN	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
controls 	controls 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
p-values  	p-values  	 NN	B-NP
were  	were  	 VBD	O
calculated 	calculated 	 VBN	O
.  	.  	 .	O
Authors 	Authors 	 NNP	O
'  	'  	 POS	O
contributions  	contributions  	 NNS	B-NP
JMS  	JMS  	 VBP	O
conceived  	conceived  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
studies  	studies  	 NNS	O
and  	and  	 CC	O
developed  	developed  	 VBD	O
the  	the  	 DT	O
initial  	initial  	 JJ	O
process  	process  	 NN	O
for  	for  	 IN	O
selecting  	selecting  	 VBG	O
diagnostic  	diagnostic  	 JJ	B-NP
rules 	rules 	 NNS	I-NP
.  	.  	 .	O
MZ  	MZ  	 NNP	B-NP
performed  	performed  	 VBD	O
the  	the  	 DT	O
statistical  	statistical  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
and  	and  	 CC	O
further  	further  	 RB	O
refined  	refined  	 VBN	O
the  	the  	 DT	O
rules  	rules  	 NNS	O
with  	with  	 IN	O
stepwise  	stepwise  	 JJ	B-NP
discrminant  	discrminant  	 JJ	I-NP
analysis 	analysis 	 NN	I-NP
.  	.  	 .	O
All  	All  	 DT	O
authors  	authors  	 NNS	O
read  	read  	 VBP	O
and  	and  	 CC	O
agreed  	agreed  	 VBD	O
with  	with  	 IN	O
the  	the  	 DT	O
final  	final  	 JJ	B-NP
manuscript 	manuscript 	 NN	I-NP
.  	.  	 .	O
